10-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-K

Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the fiscal year ended December 31, 2002.

Commission file number: 1-9972

HOOPER HOLMES, INC.

(Exact name of Registrant as specified in its charter)

New York	22-1659359
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

170 Mt. Airy Road Basking Ridge, NJ	07920
(Address of principal executive offices)	(Zip Code)

Area Code (908) 766-5000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Name of Each Exchange on Which Registered
Common Stock ($.04 par value)	American Stock Exchange

Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months and (2) has been subject to such filing requirements for the past 90 days.  Yes x    No ¨

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of the Registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendments to this Form 10-K.  ¨

Indicate by check mark whether the Registrant is an accelerated filer (as defined in Securities Exchange Act Rule #12b-2).  

Yes x    No ¨

As of February 28, 2003, there were 64,754,923 shares of Common Stock outstanding. The aggregate market value of the shares of Common Stock held by non-affiliates of the Registrant, based on the closing price of these shares on February 28, 2003 on the American Stock Exchange, was $297,167,681 based on 60,939,852 shares. For the purposes of the foregoing calculation only, all directors and executive officers of the Registrant have been deemed affiliates.

Certain information contained in the Company’s 2002 Annual Report to Shareholders and its Proxy Statement in connection with its 2003 Annual Meeting of Shareholders is incorporated by reference into Parts I, II and III of this Form 10-K.

FORM 10K

PART 1

ITEM 1.    Business

General

Hooper Holmes is one of the nation’s leading providers of outsourced risk assessment services to the life and health insurance industry and medical evaluation and claims management services to the automobile insurance industry and the workers compensation industry. We provide paramedical and medical examinations, independent medical examinations, personal health interviews and record collection, and laboratory testing, which help life insurance companies evaluate the risks associated with underwriting policies and evaluate physical injuries for property and casualty insurers. We serve our customers through our network of approximately 7,600 registered nurses, licensed practical nurses, physicians, phlebotomists and medical and EKG technicians, of which approximately 1,200 are employees and approximately 6,400 are active independent contractors. Hooper Holmes has a total employee count of 2,700. We operate through approximately 215 branch offices and 60 contract affiliate offices located in 50 states, the United Kingdom, Guam and Puerto Rico. We have over 700 life insurance company customers, and most of the top 100 in the United States.

Growth Strategy

Our growth strategy is to further enhance our industry leadership position through the vertical integration of value added services, and through the expansion of our core competencies into adjacent core businesses and markets. We will pursue this strategy by:

Providing a complete one-stop source for risk assessment services. With the reorganization of the Company in late 2002 into two distinct business units, we are now able to focus on clearly defined segments of the markets that we serve. The Health Information Business Unit (HIBU) provides a one-source order and delivery system of services to fully underwrite an application for life, health and disability insurance. These insurance company customers are better able to meet their cost containment and cycle time objectives by outsourcing their requirements to a single supplier like Hooper Holmes. The Diversified Business Unit (DBU) provides high quality, cost efficient outsourced claims management services to automobile and workers’ compensation insurance carriers, helping them increase internal productivity and profit.

Expanding core competencies geographically and vertically. The DBU presently services customers in the Metropolitan New York/Tri-State region. We can leverage our recently acquired physician network, which mostly provides independent medical exams (IMEs) for No-Fault benefits, to provide similar services in the workers’ compensation and disability insurance arenas. Most of our Portamedic operating centers throughout the U.S. have established networks of medical specialists. Our strategy is to expand those networks to include additional specialists that can provide comparable IMEs to the same national customers as well as to new ones. As we continue to expand our services nationwide, we believe we will have one of the first networks of medical specialists to service the property and casualty insurance industries on a nationwide basis.

Bundling of complementary services. A growing number of life insurance customers are contracting for services through corporate procurement departments. These purchasing agents are more inclined to contract with full service companies like Hooper Holmes that provide complete underwriting products, including examinations, laboratory analysis, attending physician statements, personal history interviews, and tele-underwriting. These services are often priced as bundled services, offering the customer cost efficiencies.

2

Continuing to pursue strategic acquisitions and marketing agreements. We intend to continue pursuing strategic initiatives that complement existing services and leverage our existing capabilities. We recently entered into a ten-year strategic marketing alliance with SwissRe and e-Nable Corporation that will allow certain customers of Swiss Re to acquire risk assessment services provided by Hooper Holmes and e-Nable under preferential terms. These covered parties will be able to reduce policy underwriting costs and issue time by leveraging Swiss Re’s buying power and acquiring these services from a single source. The DBU will continue to identify regional and local market leaders as potential acquisitions to further meet our objective of creating a national network of physician specialist panels.

Smaller regional paramedical competitors are seeking to merge or be acquired at an increasing rate. Businesses which were previously able to bill insurance companies directly must now affiliate with larger approved vendors of these life insurance companies. These affiliations are strained due to price discounting and cost pressures. As a result, entrepreneurs who have built successful businesses themselves are, in increasing numbers, electing to sell their businesses. The Company has, and will continue to consider the acquisition of these companies that have strong business models.

Continuing our commitment to technological initiatives and the promotion and implementation of industry standards. Over 1,600 underwriters and field producers registered for Portamedic F.A.S.T., making it the most popular on-line document management retrieval system in the industry. Our e-forms library is now host to 19,000 electronic forms, serving 100 customers, and assuring the use of the most current and proper state specific application forms. We have been very active in supporting the initiatives led by the Association for Cooperative Operation in Research and Development (ACORD), whose purpose is to establish electronic message standards for the life and health insurance industry. A Hooper Holmes employee is a co-chair of the ACORD Working Group Subcommittee on Underwriting Requirements. We intend to invest in the latest technologies to further enhance our operating efficiencies and to provide more Internet-based services to our customers.

In the DBU, we intend to:

• Leverage our electronic capabilities. Increasingly, our customers are moving toward a paperless environment and they need to be able to determine the status of an order in real time. From electronic ordering; to an automated tracking system; to imaging and automated data transfer; our comprehensive approach to IT solutions could result in exclusive relationships with current and new customers.

• Expand into the Workers’ Compensation (WC) market. WC is a state-mandated, comprehensive insurance program that requires employers to fund medical expenses and other costs resulting from work-related injuries and illnesses. With healthcare costs exploding and employers’ desire to keep costs to a minimum, it is management’s opinion that the demand for outsourced claims management and IME’s is increasing. With the growth in automobile no-fault claims in New York, WC currently accounts for only a small percentage of our total cases.

Leveraging our national branch network. Our national branch network provides us with broad geographical coverage capable of providing local service for insurance companies, agents and brokers across the entire United States. This company owned network positions us to become the preferred provider of health information services in an industry otherwise comprised primarily of contractor and affiliate-owned competitors. We believe that our branch network and technological infrastructure enables us to significantly increase the volume of our services with only a marginal increase in our branch operating costs.

Expanding into related lines of business. We are exploring means to enter new lines of business which leverage our existing branch network, service capabilities or customer base. For example, we continue to develop

3

services for pharmaceutical companies engaged in the clinical trials process, including specimen collection and data management. We are exploring related markets to leverage our panel of certified physician specialists, particularly in the casualty insurance arena.

Services

Health Information Business Unit (HIBU)

Portamedic—Paramedical and Medical Examinations

We perform paramedical and medical examinations of insurance policy applicants under the Portamedic trade name and provide the results to insurance companies, agents and other non-traditional insurance marketers primarily in connection with the issuance of life insurance policies. We are the leading paramedical and medical examination company in the U.S., having performed approximately 2.9 million exams for the year ended December 31, 2002 compared to approximately 3.0 million exams performed for the year ended December 31, 2001.

Since an insurance applicant may reconsider his or her purchase in the time it takes to deliver examination results, our system is designed to timely deliver applicant information to the insurance company. We strive to schedule an appointment within 24 to 30 hours of receiving the request and to complete the entire examination process in three to five days, unless the applicant desires a later appointment. Our examiners perform examinations at times and locations convenient to applicants, primarily at the applicant’s home or place of business.

As imaging technology continues to advance, Portamedic has developed exclusive capabilities to expedite completed requirements through the underwriting process. Our new Fax And Scan Today (F.A.S.T.) service indexes and images underwriting documents for immediate retrieval on our web site or through a securely encrypted File Transfer Protocol (FTP) site. Using the combined simplicity of fax processing with the latest in document management technology, clients now have the ability to case manage the workflow of pending applications and access imaged documents from a single, convenient source.

Images delivered through F.A.S.T. are password protected, making them available only to authorized personnel as designated by client companies. This can make F.A.S.T. documents simultaneously available to authorized agents, brokers and home office employees.

Since almost all of our examiners are nurses and other medically trained professionals, we are able to provide our customers with a full range of paramedical and medical examinations. Our examiners also perform other ancillary services including helping applicants understand and complete forms and obtaining consent signatures. In addition, we have dedicated customer service employees in Chicago, who help complete applications based on telephone interviews with applicants, and additional customer service employees located in service centers in Minneapolis, MN; Dallas, TX; Kansas City, KS; Santa Ana, CA; and Basking Ridge, NJ who provide general customer service support. Each insurance company has separate guidelines for determining whether an examination is required and the type of services required. The age of the applicant and the amount of life insurance applied for are the primary determinants. A policy application of a thirty-five year old male, for a $100,000 policy may only require a blood draw and exam whereas an applicant that is 60 years old seeking a $500,000 policy may need to submit to a medical exam by a physician, urine, blood and a stress EKG. For most clients, the medical underwriting requirements increase as the age of the applicant increases and the amount of insurance applied for increases. Our computer system contains more than 2,000 of these matrixes for various insurance companies. Also, our system tracks required examination forms and our new Online Forms Library makes every state form of every client in our library, available to be printed from our branch system.

4

Infolink Services Group—Personal Health Interviews and Medical Record Collection

Under the Infolink name, we offer personal health interviews and medical record collection, including attending physician statements, to our customers. Infolink reports are completed through highly automated, centrally located offices. In 2002, we provided approximately 438,000 Infolink reports, up from 410,000 reports in 2001.

Infolink reports can be ordered electronically, by fax or by phone. Approximately 65 full-time employees prepare all of the Infolink reports ordered by our customers from call centers in Austin, Texas; Philadelphia, Pennsylvania; and Louisville, Kentucky. These employees interview the applicant, his or her employer, and his or her business and personal associates. The report is then electronically transmitted or faxed to the insurance underwriter at his request. Our information systems allow us to tailor reports for each client’s needs and reduce paperwork and turnaround time for our clients. We strive to deliver our Infolink reports back to the insurance company within two to three days from the time of request.

In addition, life insurance companies may also require attending physician statements. In such cases, either a branch office or our central attending physician statement offices in Chicago and San Jose will contact the applicant’s physician, clinic or hospital to request medical records, send a written request with payment and follow-up to confirm delivery of the information.

We believe there is a large potential to increase this business by devoting increased resources and the Company will focus on this in 2003. Recently, we have appointed a senior manager, with over 25 years experience with the Company, to head this operation. We are reviewing every facet of this operation and expect it to be totally revamped by mid 2003. It is expected that solid sales initiatives will bring these improvements to the attention of our clients.

Heritage Labs

In December 1998, we acquired a 55% interest in Heritage Labs, a laboratory which provides testing services primarily for the life insurance industry. Heritage Labs processes specimens for our customers and third-party health information service providers. This acquisition has enabled us to internalize the laboratory testing process and to offer our life insurance customers a one-stop source for their health information service needs. Combined with our existing automation, we believe Heritage Labs allows us to provide a seamless service of processing, gathering and testing health information for our life insurance customers.

Insurance companies and public health entities determine which laboratory will process the samples collected from their respective applicants. In 2002, we increased our customer list to over 300 companies. The number of samples tested in 2002 was approximately 490,000 versus approximately 360,000 in 2001, an increase of 36%.

Portamedic Select^™

In 2002, Portamedic Select^™ continued to grow. Offering pre-underwriting and case management services, Portamedic Select^™ designs workflow processes that meet the specific underwriting needs of client companies, helping them issue more policies faster. Insurance carriers operating through direct marketing channels who use Portamedic Select^™ have reported measurable benefits that far exceed their expectations. Portamedic Select^™ reduced the underwriting cycle time for a major brokerage and alternative distribution carrier from ten days to three days. Portamedic Select^™ can also consolidate and coordinate the clients’ multiple supplier services and billing under a single, uniform system. In 2002, we equipped all our customer

5

service centers with this technology.

Other Health Information Business Unit Services

Under the Healthdex tradename, we evaluate services for pharmaceutical and biotechnology companies. Our goal is to leverage our health information expertise and branch network to provide outsourced information services to support clinical trials and data analysis. We also perform clinical trials monitoring which entails verifying investigator credentials and site locations, as well as insuring that proper informed consent processes are followed.

We also offer Teledex as a licensed product to the insurance industry. After providing tele-underwriting solutions to customers who have outsourced their call centers to us, we now have the technology and support systems necessary to license our innovative product to customers. As our customers strive to improve their efficiency, we believe licensing offers a unique opportunity for Hooper Holmes to further leverage its investments in technology to meet the increasing demands of the evolving life insurance industry.

Diversified Business Unit (DBU)

The Diversified Business Unit (DBU) was formed after the acquisition of D&D Associates on October 31, 2002. D&D Associates is a leading provider of Independent Medical Examinations (IME) and case management services to the automobile insurance industry. We serve customers in the New York and Tri-State region through our panel of over 800 Board Certified Physicians and Certified Insurance Consultants. Our panel provides accurate, professional and impartial medical evaluations for many of the largest automobile insurance companies in New York, including 4 of the top 10 insurers. Our success is primarily attributable to our quality control system, our review process for credentialing and qualifying physicians, and fast turnaround time. By providing service that meets or exceeds our customers’ expectations and maintaining our commitment to “Keeping the Independence in I.M.E.”, we expect to be able to continue to increase our market share with existing customers and by adding new customers.

D&D provides case management support for three categories of claims:

1) Personal Injury Protection (PIP)—The term that applies to the portion of No-Fault Insurance that will pay for the policyholder’s medical expenses and lost wages, without regard to fault.

2) Tort—Claims that result in lawsuits against an at-fault driver that can be brought for economic losses that exceed no-fault benefits.

3) Workers’ Compensation—Involves injuries sustained during the course of performing duties at work.

Each category of claim could require any or all of three types of case management services:

1) Independent Medical Examinations—An IME is a medical process whereby an insurance company requests a certified third-party doctor perform an examination of an injured or disability claimant to determine if the claimant needs further treatment and to determine what expenses are eligible for payment or reimbursement.

2) Peer and Record Review—A Peer Review is a process whereby a doctor reviews the medical necessity of a procedure performed by another doctor in the same specialty to determine whether the procedure was necessary.

6

3) Radiology Reviews—A Radiology Review is a process whereby an independent doctor reviews MRI’s, CAT scans and X-Rays. This is different than a peer review and an IME in that only the film is reviewed, not the patient or the medical records.

These services require compliance to strict protocols that begins with coordinating the insurance company’s claim review requirements with qualified, independent doctors. We review and proofread all orders and records, schedule required services, and contact claimants to coordinate medical visits and exams. Seven quality assurance checkpoints allow us to monitor the progress of each case as it flows through the process. These checkpoints insure client quality satisfaction. Under New York State law, insurers have 30 days to respond to a claim to determine if the claim will be paid, partially paid, or denied. Therefore, timeliness is critical. A large and diverse panel of board certified physicians has enabled us to provide exceptional time service and maintain an excellent relationship with our customers.

Our Network

We believe our network of branch offices and contract affiliate offices is the most extensive in our industry. We can provide an examination to any applicant in any location in the United States.

Our branch managers are responsible for the supervision of the local health information operations. A support staff coordinates examinations and reporting procedures and performs quality assurance functions. Branch sales personnel perform marketing and sales activities. Each branch office is automated with direct electronic connections to our home office in Basking Ridge, New Jersey. Orders are received by both branch offices and our corporate home office. Those orders received by our home office are electronically processed and routed to the appropriate branch. The branch office is responsible for scheduling the examination and assigning an examiner. The status of the examination is entered into the branch office system, is then retrieved and processed by the home office and made available to the customer. Once examination results are complete, they are faxed or mailed directly to the customer.

We have approximately 60 independent contract affiliate offices. Contract affiliates perform many of the same functions as our branch offices, but are independently owned and operated. Our contract affiliates provide our Portamedic services in assigned geographical areas throughout the United States and receive orders directly from our customers. Three of our contract affiliates have exclusive rights to provide examination services in areas that are not served by our branch offices. Each contract affiliate is responsible for compensating, training, hiring and supervising all of its personnel and must meet the same quality assurance standards of our branches, including necessary credentialing of its examiners. Our contract affiliates use a version of our system software that allows them to process customer billing information and obtain examination status reports.

Our Automation Systems

Our technology group is progressing on enhancements to our current IT infrastructure and applications by strengthening our imaging capabilities in our two major processes—Internet Processing and Fax and Scan Today (F.A.S.T.).

Internet Processing

Although the Internet segment of our economy may not be as explosive as it was in the late 1990’s, the technology that grew from it is clearly evident with the carriers, brokerages and agencies, which make up the insurance industry. The industry has taken up the challenges to utilize this new technology. Portamedic is determined to continue to lead as they move forward and assist by being able to meld the older legacy systems with new technological advances. This Internet technology is enabling us to interface with the larger brokerage houses

7

as they begin providing more Internet capabilities to independent agents concurrent with carriers brokering out more plan types.

F.A.S.T. Imaging

Fax and Scan Today is our technologically advanced system of imaging medical underwriting information and transmitting those images electronically to our clients’ underwriting systems, thereby eliminating the traditional bottleneck of paper reports.

Our imaging capabilities are expanding to cover all facets of our business. We can gather any paper or electronic document, bundle these documents and pass them on to the carrier, thus shortening time and service and “product to customer” cycle times. Our association with Heritage Labs also enables us to bring laboratory electronic results together with medical and personal histories.

Portamedic has also become ACORD certified as both a sender and a receiver of the TXLife XML standards. As working members of the ACORD’s standards group, we are assisting the industry in setting standards for communication of electronic transactions.

Improved Infolink and APS Systems

We have replaced our WIN Remote APS Paramedic Inspection Data (RAPID) system with our Internet web services. This makes it easier for customers to order and track the progress of pending cases. Additionally, we have a physician database that assists customers in identifying the correct physician when ordering an APS, thereby further streamlining the process.

Direct Electronic Links with Our Customers

Management believes our ability to image and electronically transmit all services to the insurance carrier has set us apart from the competition. We can send all the components of the underwriting process to the insurance client as an image. These images can be reviewed for quality by any of our Customer Service Centers in advance of transmission to the client.

We provide additional automation services to our customers through our Teledex service. Teledex is an automated service providing applicant information to our insurance customers on an expedited basis. When an insurance customer transmits an order through Teledex, a staff member pulls up a customer-specific underwriting questionnaire on his or her computer terminal and begins collecting applicant information, which includes a telephone interview with the applicant. Teledex has over 2,000 customer-specific underwriting questions in its system, which enables us to provide customized reports for each customer in a matter of hours. This process is valuable to our customers because it allows them to begin the underwriting process upon receipt of our Teledex report, rather than waiting for an examiner to perform the examination, collect the data and then return the report and examination results. Teledex additionally receives and handles orders for attending physician statements.

These customer links are designed to reduce paperwork, turnaround time and the chance that the insurance applicant will reconsider his or her buying decision by the time results are gathered.

8

Quality Assurance Program

The quality and reputation of personnel and operations are critical to the continued success of our business. Our successful implementation of quality assurance depends on our ability to recognize problems and solve them within a relatively short time period. To help do this, we employ a statistical quality control program, which allows us to monitor and quantify quality standards at many different levels of operation.

At the branch office level, quality assurance specialists monitor examiner performance. Each examiner undergoes periodic evaluations to provide feedback and ensure that any recurring mistakes are remedied. Specialists also conduct regular audits of branch office quality controls to assist branch managers in improving their performance and the quality of services examiners perform.

At the corporate headquarters level, quality assurance specialists monitor examiner performance twice each year through detailed statistical analyses of examination accuracy and reporting methodology. A quality assurance log created monthly by the corporate office tracks errors and problems with examinations and examiners, including lab errors, omissions on forms and misdirected transmission of results. The quality assurance specialists regularly evaluate examination procedures and consult with our insurance customers to address any specific problems and, where appropriate, suggest revisions to improve examination procedures and reports.

In 2002, we initiated a program to perform criminal background checks on our examiners. We hire and contract with properly trained, experienced examiners. In addition, we have developed a database of over 1,000 credentialed physicians who are approved to perform medical examinations for our customers.

Sales and Marketing

As new service capabilities have been introduced to the marketplace through the partnering of Portamedic and Heritage Labs, client companies have expressed a greater preference to work with a single point of contact for all of the services provided through Hooper Holmes. To better meet this demand, we have consolidated the Portamedic and Heritage Labs sales forces into a single unified team, focused on providing a more comprehensive approach to understanding and servicing all the underwriting needs of our customers. Additionally, we have added an account specialist position that provides our clients with technical support and e-business services.

All Portamedic, Heritage Labs and Infolink services are marketed on a national level through 17 full-time sales executives with average career tenure of approximately 20 years. Several of these sales representatives call exclusively on entities that distribute through alternative distribution channels. We serve approximately 700 life insurance companies, including their extensive network of agency, district, and brokerage offices. National sales representatives promote our quality of service and response time to examination requests and are responsible for maintaining our position on each insurance company’s approved list of examination providers. We regularly attend and occasionally sponsor customer conferences to provide national sales representatives with opportunities to further develop key relationships. The sales department was recently reorganized and now reports to the General Manager of the Health Information Business Unit. Additionally, a staff Chief Marketing Officer position was added.

At the local level, branch managers, and in certain offices, additional marketing personnel, market our services directly to the local insurance agents and managers, who have the authority to select examination providers from the list approved by insurance companies home offices. These local marketing efforts highlight the quality of our examiners and the speed and accuracy of our services, including the ability of each branch to quickly ascertain the status of each service request through our automated branch management information system.

9

The DBU is a regional leader in the $2 plus billion growing Independent Medical Examination (IME) case management services industry. Its panel of Board Certified Physicians and Certified Insurance Consultants supports the Company’s efforts to provide medical evaluations that are accurate, professional, impartial and timely.

The DBU has established extensive personal contacts with numerous clients and industry professionals. The unit has a sales force of five full-time employees who solicit and maintain new and existing customers. The sales associates are responsible for contacting new business via telephone, mail and e-mail, attending conventions and doing face-to-face sales presentations. The unit also engages in periodic direct response marketing efforts and is a member and/or participates in various industry associations and trade groups. Additionally, the unit attends national, regional, and local industry trade shows and conferences. The DBU also maintains a separate website at www.dndweb.com, that provides information to current and prospective customers.

Competition

In the HIBU market, management believes that we are the largest of the four national firms that focus primarily on providing examinations, specimen analysis, personal interviews, and medical record collection to the life insurance industry. Our largest competitors are Examination Management Services, Inc., American Para Professional Systems and LabOne, Inc. A significant number of regional and local firms also compete in our industry. Although we have exclusive relationships with a growing number of our customers, companies traditionally use two or more health information services providers. This means we face direct competition from our competitors who have existing relationships with many of our customers. Our ability to retain customers will depend on our continued ability to serve their needs and distinguish ourselves from our competitors. In management’s opinion, the principal competitive factors in our market are:

• price;

• geographic breadth of coverage;

• quality of service and examinations;

• automation and connectivity between health information providers and insurers; and

• timeliness of examination process and communication of results.

More recently, technological capabilities have become more important to meeting our customers’ needs. We are continually enhancing and expanding our technology and network infrastructure to accommodate our customers’ changing needs, including the electronic ordering and delivery of our services and online status checks. We are also adapting to the technological needs of insurance companies that are beginning to rely more on industry standards for electronic data interchange, such as the initiatives led by ACORD.

In the DBU market, our clients are some of the largest automobile insurance companies in the nation. Management estimates it holds the leading vendor position for these clients in the metropolitan New York, Nassau and Suffolk county areas for IMEs, physician peer and record reviews, and radiology reviews. We believe that there are no publicly traded direct competitors, but rather, many regional privately owned firms. Management estimates that its closest competitor in the New York City area is National Health Resources.

Service Marks and Trademarks

We have registered several service marks, including “Portamedic^®,”“Healthdex^®,” “Teledex^®,” “Infolink^®” and the Hooper Holmes logo with the United States Patent and Trademark Office. Our rights to these marks will continue as long as we comply with the usage, renewal filing and other legal requirements relating to the renewal of service marks.

10

Personnel

We employ approximately 1,450 full-time and 1,250 part-time employees, including approximately 1,200 examiners, none of whom is represented by a collective bargaining agreement. We also contract with approximately 6,400 medically trained examiners, and utilize the services of 60 contract affiliates. We hire and contract with properly trained, experienced and, when required, licensed or certified examiners. Our ability to recruit skilled personnel is essential to our continued growth and success. Management attributes our success in recruiting skilled personnel in our health information services business to the flexible work schedules and varied work assignments we offer our examiners. Management believes that these factors will enable us to continue to attract and retain qualified personnel.

Government Regulation

Certain aspects of our business are regulated by the states in which we operate and, to a lesser extent, by the federal government. In addition to licensing and certification requirements for our examiners, we are subject to regulations governing various aspects of our services, including the drawing of blood, needle disposal and specimen handling. Certain aspects of our business and that of our Heritage Labs and “684” Associates (dba D&D Associates) subsidiaries may be subject to certain provisions of the Health Insurance Portability and Accountability Act (“HIPAA”) relating to the privacy of protected health information. The Food and Drug Administration governs certain aspects of the business of Heritage Labs, including the manufacturing of specimen collection kits. Management is not aware of any pending federal or state environmental laws or regulations that would have a material adverse effect upon our business or competitive position or that would require material capital expenditures on our part to effect compliance.

On June 20, 2002, the Company, and subsequently its three principal competitors were notified by the California Department of Health Services that they were in violation of the California Business and Professions Code, with respect to the drawing of blood by phlebotomists on a mobile basis. The Company disagreed with the Department’s interpretation of the law, retained legal counsel and is working with the Department to develop a reasonable interpretation of the law and a plan that allows the Company to continue using phlebotomists to draw blood. Several times in 2002, representatives of each of the four major paramedical companies, including Hooper Holmes, Inc, met with the Deputy Chief of the California Department of Health Services (DHS) to discuss the position taken by the DHS relative to the drawing of blood by non-licensed individuals on a mobile basis. The DHS waived certain requirements determined to be not applicable to the paramedical industry and has proposed a type of limited licensure for paramedical companies. The paramedical industry is presently working out the details of such licensure with the DHS and is confident that an agreement on licensure will be reached. The Company continues to service its customers in the State of California without interruption.

Insurance and Legal Proceedings

Claims made against us arising in the course of providing health information services have not resulted in any material liability to date. We carry liability insurance in coverage amounts that we believe is customary in our business. There can be no assurance, however, that such coverage will be sufficient to cover claims made against us, that adequate insurance coverage will continue to be available to us, or that insurance coverage will be available on favorable terms. Our insurance coverage includes claims-made medical professional liability insurance with a $50,000 self insured retention per claim and claims-made non-medical professional liability insurance, a property insurance policy, a general liability policy and an umbrella insurance policy.

In the past, some state agencies have claimed that we improperly classified our examiners as independent contractors for purposes of state unemployment tax laws and that we were therefore liable for arrears of taxes, or for penalties for failure to comply with their interpretation of the laws. We received an adverse determination in the State of California, and as a result, converted our independent contractors to employees. Other similar state claims are also pending. We cannot be assured that we will prevail in these cases, or that we will not be subject to similar claims in other states in the future.

11

Web Availability

We make available free of charge on or through our web-site,www.hooperholmes.com, our annual reports on Form 10-K, quarterly reports on Form 10-Q, periodic reports on Form 8-K and all amendments to these reports as soon as reasonably practical after such reports are filed with the SEC.

ITEM 2.    Properties

We own a five-building complex located at 170 Mt. Airy Road, Basking Ridge, New Jersey. Of approximately 53,000 total square feet of office space, we maintain our operations in approximately 43,000 square feet and the balance is leased or available for lease to several tenants. Management believes that this arrangement provides for our foreseeable expansion needs.

We lease our field offices under a number of operating leases with varying terms and expirations.

ITEM 3.    Legal Proceedings

None

ITEM 4.    Submission of Matters to a Vote of Security Holders

No matters were submitted to a vote of securities holders during the fourth quarter of the fiscal year covered by this report.

PART II

ITEM 5.    Market for the Registrant’s Common Equity and Related Stockholder Matters

The common equity and related shareholder information presented under the caption “Quarterly Common Stock Price Range and Dividends” and “Investor Information—Common Stock Information” is incorporated by reference from the Company’s 2002 Annual Report to Shareholders which is Exhibit 13 to this report. As of February 14, 2003, there were 1,123 shareholders of record.

ITEM 6.    Selected Financial Data

The financial data included under the caption “Selected Financial Data” contained in the Company’s 2002 Annual Report to Shareholders which is Exhibit 13 to this report is incorporated by reference herein.

ITEM 7.    Management Discussion and Analysis of Financial Condition and Results of Operations

The discussion included under the caption “Management’s Discussion and Analysis” contained in the Company’s 2002 Annual Report to Shareholders which is Exhibit 13 to this report is incorporated by reference herein.

ITEM 7A.    Quantitative and Qualitative Disclosures About Market Risk

The discussion included under the caption “Management’s Discussion and Analysis” contained in the Company’s 2002 Annual Report to Shareholders which is Exhibit 13 to this report is incorporated by reference herein.

ITEM 8.    Financial Statements and Supplementary Data

Financial statements and supplementary data are included in the Company’s 2002 Annual Report to

12

Shareholders which is Exhibit 13 to this report and are incorporated by reference herein.

ITEM 9.    Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None

PART III

ITEM 10.    Directors and Executive Officers of the Registrant

Information contained under the captions “Nominees for Directors”, “Directors Continuing in Office”            , “Executive Officers” and “Section 16(a) Beneficial Ownership Reporting Compliance” in the Company’s Proxy Statement for the Annual Meeting of Shareholders to be held on May 20, 2003 is incorporated herein by reference.

ITEM 11.    Executive Compensation

Information contained under the captions “Compensation of Executive Officers,” “Compensation of Directors”, “Option Grants in Last Fiscal Year”, “Aggregated Option Exercises in Last Fiscal Year and Fiscal Year-End Option Values”, “Equity Compensation Plan Information”, “Report of the Executive Compensation Committee” and “Employment Contracts and Change-in-Control Arrangements” in the Company’s Proxy Statement for the Annual Meeting of Shareholders to be held on May 20, 2003 is incorporated herein by reference.

ITEM 12.    Security Ownership of Certain Beneficial Owners and Management

Information contained under the caption “Stock Ownership of Certain Beneficial Owners and Management” in the Company’s Proxy Statement for the Annual Meeting of Shareholders to be held on May 20, 2003 is incorporated herein by reference.

ITEM 13.    Certain Relationships and Related Transactions

Information contained under the caption “Certain Relationships and Related Transactions” in the Company’s Proxy Statement for the Annual Meeting of Shareholders to be held on May 20, 2003 is incorporated herein by reference.

ITEM 14.    Controls and Procedures

Within 90 days prior to the date of this report, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-14 under the Securities Exchange Act of 1934, as amended. Based upon that evaluation, the Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures are effective in timely alerting them to material information relating to the Company required to be included in the Company’s periodic SEC filings.

There have been no significant changes in the Company’s internal controls or in other factors which could significantly affect internal controls subsequent to the date the Company carried out its evaluation.

13

PART IV

ITEM 15. Exhibits, Financial Statement Schedules and Reports on Form 8-K

(a) (1) The following financial statements and independent auditors’ report are included in the

Registrant’s 2001 Annual Report to Shareholders.

Independent Auditors’ Report

Consolidated Balance Sheets—

December 31, 2002 and 2001

Consolidated Statements of Income—

Years ended December 31, 2002, 2001 and 2000

Consolidated Statements of Stockholders’ Equity—

Years ended December 31, 2002, 2001 and 2000

Consolidated Statements of Cash Flows—

Years ended December 31, 2002, 2001 and 2000

Notes to Consolidated Financial Statements

(2) Schedules are omitted because they are not required, inapplicable, or the

information is otherwise shown in the financial statements or notes thereto.

(3) Exhibits included herein

(b) Report on Form 8-K filed November 8, 2002 reporting the acquisition of all the issued and outstanding common stock of “684” Associates, Ltd., doing business as D&D Associates, and subsequently amended by Form 8-K/A filed December 30, 2002 reporting the financial statements of the business acquired.

(c)

EXHIBIT

3.1	Restated Certificate of Incorporation of Hooper Holmes, Inc., as amended (1)
3.2	Certificate of Amendment of the Certificate of Incorporation of Hooper Holmes, Inc. (2)
3.3	Bylaws of Hooper Holmes, Inc., as amended (3)
4.1	Rights Agreement between Hooper Holmes, Inc. and First City Transfer Company (4)
4.2	Amendment to Rights Agreement

(1) Incorporated by reference to Exhibit 3.1 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1992.

(2) Incorporated by reference to Exhibit 3.2 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1999.

(3) Incorporated by reference to Exhibit 3.3 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1999.

(4) Incorporated by reference to Exhibit 4.1 of the Company’s Report on Form 10-K for the fiscal year ended December 31, 2000.

14

10.1	Amended Employee Retention Agreement by and between Hooper Holmes, Inc., and James M. McNamee (5)
10.2	Form of Indemnification Agreement (6)
10.3	Hooper Holmes, Inc. 1992 Stock Option Plan as amended (7)
10.4	Employee Stock Purchase Plan (1993) of Hooper Holmes, Inc., as amended (8)
10.5	Hooper Holmes, Inc. 1994 Stock Option Plan (9)
10.6	Amended and Restated Revolving Credit and Term Loan Agreement between Hooper Holmes, Inc. and First Union National Bank and Fleet Bank, N.A. (10)
10.7	CEO Stock Option Agreement (11)
10.8	1997 Stock Option Plan (12)
10.9	1997 Director Option Plan (13)
10.10	Employee Retention Agreement by and between Hooper Holmes, Inc. and Executive Officers of Hooper Holmes, Inc. (14)
10.11	1999 Stock Option Plan (15)
10.12	2002 Stock Option Plan (16)
13	2002 Annual Report to Shareholders
21	Subsidiaries of Hooper Holmes, Inc.
23	Consent of KPMG LLP
24	Power of attorney
99.1	Chief Executive Officer and Chief Financial Officer Certification under Section 906 of the Sarbanes-Oxley Act of 2002

(5) Incorporated by reference to Exhibit 10.3 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1990.

(6) Incorporated by reference to Exhibit 10.4 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1990.

(7) Incorporated by reference to Exhibit 10.11 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1992.

(8) Incorporated by reference to Exhibit 10.6 of the Company’s Annual Report on Form 10-K or the fiscal year ended December 31, 1999.

(9) Incorporated by reference to Exhibit 10.16 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1994.

(10) Incorporated by reference to Exhibit 10.1 of the Company’s Form 10-Q for the quarter ended September 30, 1999.

(11) Incorporated by reference to Attachment to the Company’s Proxy Statement for the Annual Meeting of Shareholders held on May 27, 1997.

(12) Incorporated by reference to Exhibit 10.10 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1997.

(13) Incorporated by reference to Exhibit 10.11 of Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1997.

(14) Incorporated by reference to Exhibit 10.14 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1996.

(15) Incorporated by reference to Exhibit 10.13 of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 1999.

(16) Incorporated by reference to Attachment to the Company’s Proxy Statement for the Annual Meeting of Shareholders held on May 21, 2002.

15

SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

HOOPER HOLMES, INC.
(Registrant)
/S/    JAMES M. MCNAMEE
By:	James M. McNamee
	President & CEO
Date:	March 31, 2003

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the Registrant and in the capacities and on the dates indicated:

/S/    JAMES M. MCNAMEE James M. McNamee	Director President & CEO	Date: March 31, 2003
*Benjamin A. Currier	Director	Date: March 31, 2003
*Quentin J. Kennedy	Director	Date: March 31, 2003
*Kenneth R. Rossano	Director	Date: March 31, 2003
*Elaine Rigolosi	Director	Date: March 31, 2003
*John E. Nolan	Director	Date: March 31, 2003
G. Earle Wight	Director	Date: March 31, 2003
/S/    FRED LASH Fred Lash	Senior V.P., Treasurer and Chief Financial and Accounting Officer	Date: March 31, 2003

* James M. McNamee, by signing his name hereto, does hereby sign this report for the persons before whose printed name an asterisk appears, pursuant to the power of attorney duly executed by such person and filed as Exhibit 24 hereto with the Securities and Exchange Commission.

/S/    JAMES M. MCNAMEE

James M. McNamee

16

CERTIFICATIONS

I, James M. McNamee, certify that:

1. I have reviewed this annual report on Form 10-K of Hooper Holmes Inc.;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared.

b) evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report the (the “Evaluation Date”); and

c) presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

6. The registrant’s other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

/s/    James M. McNamee

James M. McNamee

Chairman, President, and Chief Executive Officer

March 31, 2003

17

CERTIFICATIONS

I, Fred Lash, certify that:

1. I have reviewed this annual report on Form 10-K of Hooper Holmes Inc.;

2. Based on my knowledge, this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report;

3. Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:

a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this annual report is being prepared.

b) evaluated the effectiveness of the registrant’s disclosure controls and procedures as of a date within 90 days prior to the filing date of this annual report the (the “Evaluation Date”); and

c) presented in this annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent function):

a) all significant deficiencies in the design or operation of internal controls which could adversely affect the registrant’s ability to record, process, summarize and report financial data and have identified for the registrant’s auditors any material weaknesses in internal controls; and

b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls; and

6. The registrant’s other certifying officers and I have indicated in this annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.

/s/    Fred Lash

Fred Lash

Senior Vice President, CFO & Treasurer

March 31, 2003

18

EX-4.2

EXHIBIT 4.2

AMENDMENT TO RIGHTS AGREEMENT

The Rights Agreement dated as of June 16, 2000 between Hooper Holmes, Inc. and First City Transfer Company is hereby amended as follows:

1. First City Transfer Company is hereby removed as Rights Agent and Registrar and Transfer Company, a New Jersey corporation (“R&T”), is hereby appointed as the successor Rights Agent with the same powers, rights, duties and responsibilities as if it had been originally named as Rights Agent.

2. Section 4.4 is hereby amended by deleting the fifth sentence and in its place substituting a new fifth sentence to read as follows:

“Any successor Rights Agent, whether appointed by the Company or by such a court, shall be a corporation organized and doing business under the laws of the United States or of any state in the United States, in good standing, having its principal offices in the State of New York or New Jersey, which is authorized under such laws to exercise the powers of the Rights Agent contemplated by this Agreement and is subject to supervision or examination by federal or state authority and is registered as a Transfer Agent in accordance with the applicable provisions of the Securities Exchange Act of 1934, as amended, and is qualified to act as a Transfer Agent under the rules of the New York Stock Exchange.”

3. Section 5.9 is hereby amended to show the Rights Agent’s address as follows:

Registrar and Transfer Company

Attn: Account Executive

10 Commerce Drive

Cranford, New Jersey 07016

IN WITNESS WHEREOF, the parties listed below have caused this Amendment to be duly executed on this 19th day of December, 2002.

HOOPER HOLMES, INC.		REGISTRAR AND TRANSFER COMPANY
By:		By:
	/S/    ROBERT WILLIAM JEWETT		/S/    WILLIAM P. TATLER
	Robert William Jewett Senior Vice President, General Counsel & Secretary		William P. Tatler Vice President

EX-13

HOOPER HOLMES, INC.

ANNUAL REPORT 2002

Hooper Holmes, a 104 year-old company, is the nation’s #1 provider of health information utilized in underwriting life and health insurance policies. Through more than 200 locations in all 50 states, Guam, Puerto Rico and the United Kingdom, our network of experienced medical professionals conducts paramedical examinations. Our customers – primarily life, health and disability insurers – use the results of these Portamedic exams for the purpose of properly assessing risk to make well-informed underwriting decisions. We also provide independent medical examination case management services to the casualty claim and worker’s compensation markets. Ancillary products are provided through our Healthdex, Infolink, Portamedic Select and Teledex services and our Heritage Labs division, including health information and data gathering services used by the biotech and pharmaceutical industries. Hooper Holmes is relied upon by most of the top 100 life and health insurers in the U.S. – some exclusively – for their health information needs, as well as some of the largest automobile insurance companies in the nation, making us the undisputed leader in the industry.

contents

Financial Highlights	1
Letter to Shareholders	2
Q&A: Review of Operations	4
The Technological Edge and The Human Touch	9
Health Information Business Unit	10
Diversified Business Unit	11
Hooper Holmes At a Glance	12
Management’s Discussion and Analysis	13
Consolidated Financial Statements	23
Notes to Consolidated Financial Statements	27
Independent Auditors’ Report	45
10 Year Selected Financial Data	46
Directors and Officers	48
Investor Information	49
Quarterly Information	50
Glossary	Inside Back Cover

Financial Highlights

	Years ended December 31,
(dollars in thousands, except per share data and ratios)	2002		2001		2000
Revenues	$	260,317	$	245,185	$	274,974
Operating income		21,872		24,111		32,633
Net income		14,293		15,247		20,964
Earnings per share — basic	$	.22	$	.24	$	.32
Earnings per share — diluted	$	.21	$	.23	$	.31
Weighted average number of shares — basic		64,868,163		64,895,764		64,830,697
Weighted average number of shares — diluted		67,229,119		67,618,151		68,377,742
Return on stockholders’ equity		7.1%		7.9%		14.9%
Dividend payout rate		18.1%		12.8%		9.2%
Net cash provided by operating activities	$	27,826	$	33,559	$	33,442
Working capital		58,776		94,059		93,305
Cash dividends paid		2,592		1,948		1,925
Cash dividend per share		.04		.03		.03
Book value per average share		3.06		2.90		2.79
Closing stock price per common share	$	6.14	$	8.95	$	11.06
Current ratio		3.7:1		5.6:1		7.2:1
Quick ratio		3.4:1		5.3:1		6.9:1

Per share and share amounts have been adjusted to reflect a two for one stock split effective April 12, 2000.

All graphs presented herein are continuing operations.

Annual Report 2002    1

To our shareholders

[PICTURE] Consistent with its reputation as the technology leader in the industry, Hooper Holmes continued to make strides in accelerating the speed and efficiency of the underwriting process in 2002.

The year 2002 was an exciting, progressive year for Hooper Holmes. We focused our efforts on securing our leadership position in the health information industry and developing diverse growth opportunities that are complementary to our core business offerings. As a result, we made significant progress on a number of fronts, greatly enhancing the long-term growth prospects of our Company.

Our accomplishments in 2002 underscore the importance of our acquisition strategy. We completed two major acquisitions, both of which met with our strict criteria in terms of being accretive to earnings, having a focus aligned with our existing business, and extending our reach into key insurance markets.

The first of these two acquisitions, Medicals Direct Group, marked a milestone for Hooper Holmes – our entry into the United Kingdom (U.K.) market. Medicals Direct is the market leader in the U.K. providing paramedical examinations and underwriting services to the life insurance industry. Leveraging this mutually beneficial acquisition, we expect to expand into Continental Europe, a market that offers attractive opportunities for an enterprise that combines Hooper Holmes’ highly evolved organizational structure and Medicals Direct’s presence. Moreover, the acquisition gives us the opportunity to expand our service offerings to our U.S.-based life insurance clients by providing them with fully integrated life insurance underwriting services.

The second of our major acquisitions on October 31, 2002 was D&D Associates, a leading New York-based provider of Independent Medical Examination (IME) case-management services. In 2002, D&D generated annual revenues totaling approximately $32 million, two months ($5.1 million) of which are included in Hooper Holmes’ results of operations. D&D’s services support Personal Injury Protection claims, Automobile No-Fault Liability claims and Workers Compensation claims, primarily for property and casualty insurers and claims reviewers. The $2 billion-plus IME industry is extremely fragmented. Hooper Holmes believes that its financial and technological strength coupled with the proven track record of D&D’s management team and business model will be a winning combination for the successful expansion of D&D’s business into other select geographic areas. Another important advantage of this acquisition is that it enables us to expand our relationship with a number of our established core-business customers, many of whom also require IME services.

2    Hooper Holmes, Inc.

In order to maximize the growth prospects of our new and established businesses, to maintain sharp focus and to increase accountability for improved operating results, Hooper Holmes refined its business structure in late 2002 by creating two distinct operating divisions. The Health Information Business Unit (HIBU) includes our core health information operations: Portamedic^®, Infolink, Heritage Labs and Medicals Direct. By combining all four of our health information divisions into one vertically integrated operating unit, Hooper Holmes believes it can more effectively achieve its cross-selling goals, thus providing its customers with a full range of paramedical and related services and a higher level of responsiveness. We recently appointed Alexander Warren, a 21-year veteran of Hooper Holmes, General Manager of our core-business oriented HIBU. The Diversified Business Unit (DBU), formed to capitalize on emerging trends in the insurance industry, includes D&D Associates. During 2002, we appointed Steven Kariotis, who has been with our Company for more than two decades, as General Manager of this entrepreneurial unit.

Consistent with its reputation as the technology leader in the industry, Hooper Holmes continued to make strides in accelerating the speed and efficiency of the underwriting process in 2002. Responding to the convenience and cost savings enabled by our advanced automation, our customers are increasingly incorporating our technology-based solutions into their underwriting strategies. More exams are being ordered via the Portamedic Web site, more customers are using Portamedic F.A.S.T.^™ to electronically generate and store their documents and more insurers are registering their exam forms on our Online Forms Library.

Hooper Holmes’ financial results for 2002 were reasonably solid despite a challenging market environment. Revenue for 2002 increased six percent to $260.3 million, from $245.2 million for 2001. Net income for 2002 was $14.3 million, or $0.21 per diluted share, versus $15.2 million, or $0.23 per diluted share for 2001. An after-tax adjustment of $4.1 million, or $0.06 per diluted share resulted from the write off of the e-Nable investment in the second and third quarters of 2002. Net income for 2001 would have been approximately $0.03 per diluted share higher if the Statement of Financial Accounting Standards No. 142 (goodwill amortization) had been applied in 2001, as our Company was required to do this year.

Although the life insurance industry had a challenging year in 2002, our longer-term assessment of life insurance trends remains favorable. As industry conditions improve, we anticipate significant growth for Hooper Holmes, which is extremely well positioned to benefit from increased demand for health information services. In addition, because we have prudently diversified our business, we believe that we will derive a greater percentage of our Company’s future revenue from the newly formed DBU.

We would like to take this opportunity to thank our employees, who continue to inspire us with their commitment to providing the very best service to our customers. It is because of them that we are able to pursue our goals with such confidence. We also extend our gratitude to our customers for their business and to our shareholders for their faith in our abilities to execute our business plans.

James M. McNamee

Chairman, President and Chief Executive Officer

Annual Report 2002    3

Q&A: Review of Operations

Q:    How does the restructuring of Hooper Holmes into two distinct business units benefit your customers and enhance the long-term growth prospects of the Company?

A:    The Health Information Business Unit (HIBU) and the Diversified Business Unit (DBU) are able to devote 100 percent of their energy to their respective markets. Under the leadership of separate General Managers, each business unit focuses on achieving specific growth goals, and each is accountable for its results. The HIBU, our core-business unit, provides us with more significant cross-selling opportunities and provides our customers with easy access to the full range of Hooper Holmes’ paramedical services, enhancing our ability to deepen our relationship with our customers. The DBU, our unit for ancillary emerging growth businesses, is free to operate with a more entrepreneurial style, while reaping the significant benefits of Hooper Holmes’ established technology infrastructure, financial support and management expertise. As this unit grows, we anticipate that it will provide us with an increasing percentage of revenue derived from non-core business activities. This gives us a degree of protection from periods of softness in the life insurance industry and provides us with new ways to serve our established customers and attract new ones.

Q:    Hooper Holmes has completed a number of strategic acquisitions over the past seven years. Can you describe the vision behind these acquisitions? How do these acquisitions fit into the Company’s overall strategy?

4    Hooper Holmes, Inc.

A:    Combined with continuous technological innovation and organic development, Hooper Holmes’ acquisition strategy has become an integral part of our Company’s overall long-term growth strategy. These ongoing initiatives serve the same goal — to provide the highest possible level of service to a growing customer base. In line with our conservative management approach, we are extremely selective about our acquisitions and ever mindful of the effects that each acquisition has on our current and future financial position. Whether the acquisition is for the purpose of advancing our technological capabilities, expanding our core-business offerings, further improving our geographic coverage or breaking into a related market, we will only pursue it if it meets our well- defined criteria. Each acquisition must be accretive to our earnings and have a business focus that clearly advances our goals. Hooper Holmes has been fortunate to identify a number of com-

Combined with continuous technological innovation and organic development, Hooper Holmes’ acquisition strategy has become an integral part of our Company’s overall long-term growth strategy.

Annual Report 2002    5

Q&A

panies over the past seven years that have fit these criteria. Our acquisition program has been well executed and most have met or exceeded our expectations. Overall, Hooper Holmes is very confident in its acquisition strategy as a means of further strengthening our Company’s position in the industry and providing opportunities to diversify our revenue streams.

Q:    During 2002, Hooper Holmes acquired Medicals Direct Group based in the United Kingdom (U.K.). Does this acquisition mark the beginning of an international expansion for Hooper Holmes?

A:    As a leading paramedical and underwriting services provider to the insurance, legal and corporate sectors in the U.K., Medicals Direct Group provides Hooper Holmes opportunities to expand its business in the U.K. and throughout Continental Europe. We believe that there will be a thriving viable market for

Providing underwriting services to customers on both sides of the Atlantic is a first for our industry.

6    Hooper Holmes, Inc.

Medicals Direct Group’s unique, real-time, 24x7 underwriting services among Hooper Holmes’ established customers who operate in the U.S., as well as in the U.K. and Europe. By outsourcing such front-end services, insurance companies can operate more efficiently and save on overhead expenses. As a result, there is an emerging trend among insurance companies for the outsourcing of these services. Providing underwriting services to customers on both sides of the Atlantic is a first for our industry. Indeed, Hooper Holmes is the only company in the industry that is currently able to offer such service coverage to its customers. In addition to offering Medicals Direct services to Hooper Holmes’ customers, we anticipate significant revenue increases resulting from Medicals Direct’s organic growth in the U.K. and from strategic acquisitions.

Q:    What impact do you expect life insurance industry trends to have on Hooper Holmes in the long term?

A:    Hooper Holmes has a very positive long-term outlook for the life insurance industry. There are a number of industry trends fueling our optimism, including the growth of alternative distribution channels (ADCs), an increase in the size of the average policy, a greater variety of insurance products with compelling investment features and a reduction in the number of approved national health information providers. We believe that the end result of these trends will be greater demand for Hooper Holmes’ services. As a testament to our confidence in the industry and the growth potential of our Company, Hooper Holmes bought back more than one million shares of its stock during 2002.

Q:    Are the demands on life insurance companies increasing, as is the case for companies in so many industries? If so, how is it affecting Hooper Holmes?

A:    Yes, life insurance has become an increasingly competitive industry. Insurance companies are making decisions more quickly regarding health information services and are demanding more agility, speed and responsiveness from their providers. This is actually an

Annual Report 2002    7

Q&A

advantage for Hooper Holmes because our technological capabilities are unsurpassed in the industry, supporting products and services that enable our customers to underwrite policies with maximum speed and efficiency.

Q:    Can you discuss the Company’s commitment to corporate governance? Have there been any internal changes in light of the broader business environment?

A:    Corporate governance is very important to our organization. As such, Hooper Holmes adheres to the highest standards for corporate governance and continually explores new and better ways to ensure the most reliable, fair, accurate and timely dissemination of information to our shareholders and the financial community. We are proud of the experience and integrity of our management team, which has long maintained a strict policy of conservatism both in terms of our accounting practices and our growth strategy. Hooper Holmes has been in business for 104 years – long enough to understand that there are no shortcuts to long-term success and there are no substitutes for integrity and accountability.

Q:    How long will it take for Hooper Holmes to integrate the acquisitions of Medicals Direct Group and D&D Associates?

A:    We expect to have their related integration plans completed by mid-2003. This includes financial reporting, internal controls and some administrative, back-office support. Both Medicals Direct and D&D are freestanding businesses with highly competent management in place who have achieved very impressive results for their respective companies.

Our technological capabilities are unsurpassed in the industry,

supporting products and services that enable our customers to underwrite

policies with maximum speed and efficiency.

8    Hooper Holmes, Inc.

The technological edge

The innovative technology and dedicated people of Hooper Holmes are two of the factors that contribute most significantly to our position as the health information services provider of choice among the country’s largest and most prestigious life insurance companies.

Speed, agility, accuracy, efficiency and convenience. Our technology delivers results that are far and away the best in the industry. Hooper Holmes boasts the industry’s most automated branch-management and operating systems for unmatched connectivity between our home office, our 215 branch offices, our insurance company customers and their agents and brokers. Portamedic Select^™, the industry’s most comprehensive and efficient case-management process, enables insurers to issue policies 70 percent faster than they could with traditional methods. Teledex speeds the underwriting process with telephone interviews that collect the information

... and the human touch

underwriters need to make faster, better informed decisions. Portamedic F.A.S.T.^™ allows customers to retrieve, view and print images of attending physician statements, examinations and personal health interviews within 24 hours of their completion. And nearly 100 Hooper Holmes customers have registered a total of 65,000 forms on our Online Forms Library, which catalogs insurance exam forms online and organizes them by participating client and state. In short, Hooper Holmes defines “state of the art” for the health information services industry.

We also define “service.” Our employees are committed to providing unsurpassed service to our customers. With a diverse range of complementary skills, the people of Hooper Holmes meet the very highest standards for responsiveness to the needs of our discerning customers – some 700 life insurance companies, including virtually all of the top 50 in the industry. Because we understand the importance of retaining the best people, Hooper Holmes provides good benefits and a comfortable and professional work environment for its employees. Our people take pride in their work, and we take pride in our people.

Annual Report 2002    9

The Health Information

Business Unit

Hooper Holmes’ Health Information Business Unit (HIBU) encompasses all of our Company’s health information business divisions. The HIBU ties together all of the paramedical, laboratory, Attending Physician Statement and inspection report services required to underwrite life, health and disability insurance.

[PHOTO]

Alexander Warren

Senior Vice President

General Manager,

Health Information Business Unit

10    Hooper Holmes, Inc.

The Diversified

Business Unit

Hooper Holmes’ Diversified Business Unit (DBU) complements our Company’s core health information business. Bolstered by the financial strength and advanced technological capabilities of our established organization, the DBU is the more entrepreneurial, emerging-growth side of our operations.

[PHOTO]

Steven Kariotis

Senior Vice President

General Manager,

Diversified Business Unit

Annual Report 2002    11

HIBU

Heritage Labs

A full-service progressive laboratory serving more than 300 life insurance companies and public health facilities, Heritage Labs is one of the fastest growing labs in the industry.

Medicals Direct Group

The market leader in the U.K. for providing paramedical examinations and underwriting services to the life insurance industry, medical services through company-operated clinics, and medical reports to the legal profession

Portamedic^®

Conducts physical examinations, testing and personal health interviews primarily for the life and health insurance industry

Infolink Services Group

Provides inspection reports and Attending Physician Statements to life, health and disability insurance underwriters

The Products

· Paramedical Examinations

· Blood Draws

· Attending Physician Statements

· Laboratory Services

Recent Acquisition

Medicals Direct Group Plc, United Kingdom

· Leading provider of medical underwriting services to the U.K. life insurance industry

· Tender offer to all shareholders of this public company on the London market. All shares tendered.

· Management team remains in place

The Plan

· Be price competitive

· Grow market share

· Re-establish Infolink business

· Cross-sell with Heritage Lab business

The Health Information Business Unit (HIBU) and the Diversified Business Unit (DBU) are able to devote 100 percent of their energy to their respective markets…

DBU

…each business unit focuses on achieving specific growth goals.

The Acquisition

· Effective November 1

· Management team intact

· Principal seller consulting for Hooper Holmes

· Contingent performance incentive in place

The Company

D&D total revenues 2002:

$31.8 million

($5.1 million included in Hooper Holmes’ results)

Clients:

45

Employees:

123

Services:

Provides Independent Medical Exams, Peer Reviews and Radiology Reviews to insurance companies

The Plan

D&D Associates is a major presence in the New York market. We plan to extend their expertise to other states, and expand their services more significantly in the New York workers compensation market.

The Management

Three senior managers remain in their respective Operations, Claims and Sales positions. All three had insurance company claims experience before joining D&D.

D&D Associates

A leading New York provider of Independent Medical Examination (IME) case management services that support personal injury protection, automobile no-fault liability, and worker’s compensation claims

Hooper Holmes at a Glance

OUR COMPANY

Hooper Holmes is the nation’s leading provider of underwriting health information services and is a growing provider of independent medical examination services. Through company-owned branch locations in all fifty states, Guam, Puerto Rico and the U.K., Hooper Holmes’ network of experienced medical professionals conduct physical examinations, testing and personal health interviews, primarily for the life and health insurance industries.

OUR SERVICES

Hooper Holmes offers a wide range of health information services for gathering and managing insurance underwriting requirements and independent medical examinations.

OUR CUSTOMERS

Hooper Holmes is a provider of health information and underwriting services to 700 life, health and disability insurers in the United States, including virtually all of the 50 top insurers in the industry. Through our wholly owned subsidiaries, we also serve property and casualty insurers, indemnity carriers, law firms and corporate clients.

2002 HIGHLIGHTS

Revenues increased 6.2 percent to $260.3 million

Ÿ Operating income totaled $21.9 million, which includes a pre-tax charge of $6.7 million related to e-nable

Ÿ Gross margin increased to 28.6 percent

Ÿ SG&A as a percentage of revenue declined more than 100 basis points to 17.7 percent

Ÿ Net income totaled $14.3 million, which includes an after tax charge of $4.1 million related to e-nable

Ÿ DSO for traditional paramedical business was a record low of 31 days

Ÿ Total stockholders’ equity increased nearly five percent

Operational:

Ÿ Entry into the U.K. market through Medicals Direct Group acquisition

Ÿ Entry into the IME market through D&D Associates acquisition

Ÿ Refinement of the Hooper Holmes organizational structure: establishment of the Health Information Business Unit and the Diversified Business Unit

Financial:

OUR OUTLOOK

Positive long-term industry trends, the best products and services in the industry, and employees who are dedicated to providing the highest level of service and responsiveness all contribute to Hooper Holmes’ confidence in its ability to maintain its strong leadership position in the industry. In addition, our entry into new markets provides us with exciting opportunities for growth and diversification.

12    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Management’s Discussion and Analysis

Results of Operations

2002 Compared to 2001

Total revenues for 2002 increased 6% to $260.3 million from $245.2 million for 2001. The number of paramedical examinations performed decreased from 2,981,000 to 2,921,000, a decrease of 2%. The decrease in the number of paramedical examinations performed is the result of reduced life insurance application activity, particularly in the second half of 2002. The decrease in the number of examinations was offset by an increase in the average revenue per examination of approximately 4%. Management believes the percentage increase in the average revenue per examination is due to higher prices per examination based on selling value added services such as Portamedic Select and Portamedic F.A.S.T. The number of Infolink reports increased 7% to 438,000 for the year 2002, from 410,000 for the year 2001. The increase in the number of Infolink reports is due to increased volume from existing clients brought on by the Company’s Portamedic F.A.S.T. technology, which provides clients with a quicker turnaround for Attending Physician Statements (APS’s).

Additionally, during the third and fourth quarters of 2002, the Company completed the acquisitions of Medicals Direct Group, located in the United Kingdom, and D&D Associates, located in New York. (See Note 2 to the consolidated financial statements.) The Medicals Direct Group acquisition and the D&D Associates acquisition contributed aggregate revenue of $9.0 million in 2002 from the dates of their respective acquisitions.

Our future revenue stream is dependent upon the life insurance industry and the number of new policies being written which require medical underwriting information. The MIB Group, Inc., a provider of information and database management services, reported that life insurance applications were down 4.2% in the fourth quarter of 2002 compared to the fourth quarter of 2001, contributing to the Company’s paramedical revenue decreasing by 8.2% for the fourth quarter of 2002 compared to the fourth quarter of 2001.

Management expects insurance application activity to resume more traditional levels in 2003. We are confident we will hold our market share. Pricing of our services has become a significant factor in our competitive environment but we are confident that our field owned branch structure, and branch and automation efficiencies will allow us to continue reporting improved results. The Infolink portion of our business is targeted for a major reorganization and sales and marketing emphasis for 2003. We expect to increase market share from both internal growth and through selected acquisitions.

The ADC market, while not growing explosively as it has in prior years, remains strong and we are optimistic on its prospects for further growth.

The Company’s majority owned subsidiary, Heritage Labs, provides laboratory testing services for specimens collected during paramedical examinations. Heritage Labs revenue grew 37% in 2002 vs. 2001, and the number of samples tested increased 36% to 490,000 for 2002, versus 360,000 for 2001. The Company believes that Heritage Labs’ growth is the result of aggressive competitive pricing, coupled with offering

Annual Report 2002    13

Hooper Holmes, Inc. and Subsidiaries

insurance companies the convenience of a one-stop shop for their health information needs. Offering combined laboratory and paramedical pricing and services is increasingly more common in this competitive landscape.

The Company’s cost of operations in 2002 totaled $185.8 million compared to $175.3 million for 2001, and as a percentage of revenues, remained relatively flat, decreasing slightly to 71.4% for 2002, from 71.5% for 2001. Cost of operations for the paramedical examination business increased from 71.7% in 2001 to 72.2% in 2002. The increase is the result of additional blood kit costs in 2002 of approximately $0.7 million and a sales tax issue related to the purchase of blood kits of approximately $0.5 million. Both issues were resolved in the latter part of 2002. The above cost increases in the paramedical examination business were offset by lower cost of sales percentages associated with the acquired Medicals Direct Group and D&D Associates companies, completed in the third and fourth quarters of 2002, respectively. Cost of sales associated with Heritage Labs remained relatively unchanged.

Selling, general and administrative (SG&A) expenses totaled $45.9 million for 2002, compared to $45.8 million for 2001, and as a percentage of revenues totaled 17.6% compared to 18.7%, respectively. The decrease, as a percentage of revenues, is due to higher revenues and no dollar increase in SG&A costs in 2002. In addition, amortization of intangible assets was $2.9 million for 2002, compared to amortization of goodwill and intangible assets of $6.9 million for 2001. The decrease is attributable to the adoption of Financial Accounting Standards Board (“FASB”), Statement No. 142 “Goodwill and Other Intangible Assets,” which the Company adopted January 1, 2002. Statement of Financial Accounting Standards (“SFAS”) 142, requires that goodwill and intangible assets with indefinite useful lives no longer be amortized. The favorable effect of Statement of Financial Accounting Standards (“SFAS”) 142, was offset by increased SG&A costs primarily in the area of general insurance, corporate legal, employee insurance programs and the SG&A associated with the Medicals Direct Group and D&D Associates acquisitions completed in the latter part of 2002.

During the second quarter of 2002, the Company recorded a 25% write down of the carrying value of its investment in and advances to e-Nable Corporation, which resulted in a pre-tax charge of $1.6 million, or $1.0 million after tax. The adjustment was estimated based on an assessment of the fair value of the investment and was mainly the result of the difficulty e-Nable has had in securing additional financing in the capital markets. During the third quarter of 2002, the Company wrote off the remaining carrying value of its investment in and advances to e-Nable Corporation which resulted in a pre-tax charge of $5.1 million, or $3.1 million after tax. The Company continues to pursue the strategic benefits offered by e-Nable. The adjustment was based on the continuing assessment of the carrying value of the investment, given that e-Nable has been unsuccessful in its attempt to secure additional capital. The Company has no future obligation or intent to fund the operations of e-Nable.

Accordingly, the Company’s operating income decreased 9.3% to $21.9 million for 2002 from $24.1 million for 2001, and as a percentage of revenues, decreased to 8.4% compared to 9.8%, respectively.

Interest expense decreased to $0.1 million for 2002, compared to $0.2 million for 2001 as a result of lower interest rates. Interest income in 2002 consisted of interest earned on invested funds, the average balance of which was $70.8 million in 2002, compared to $72.7 million in 2001. Interest income decreased to $2.3 million in 2002, compared to $3.3 million in 2001 and is due to lower average invested funds and lower interest rates. Other income (expense) for 2002 is primarily the minority interest expense associated with the Company’s investment in Heritage Labs, and for 2001, includes a provision for legal matters of $1.2 million.

The effective tax rate was 39% and 41% in 2002 and 2001, respectively. The rate was lower in 2002 due

14    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

to the elimination of certain non-deductible goodwill amortization as a result of the adoption of SFAS 142.

Net income for 2002 was $14.3 million or $.21 per diluted share versus $15.2 million or $.23 per diluted share for 2001.

Inflation did not have a significant effect on the Company’s operations in 2002.

On June 20, 2002, the Company, and subsequently its three principal competitors, were notified by the California Department of Health Services that they were in violation of the California Business and Professions Code, with respect to the drawing of blood by phlebotomists on a mobile basis. The Company disagreed with the Department’s interpretation of the law, retained legal counsel and is working with the Department to develop a reasonable interpretation of the law and a plan that allows the Company to continue using phlebotomists to draw blood. Several times in 2002, representatives of each of the four major paramedical companies, including Hooper Holmes, Inc., met with the Deputy Chief of the California Department of Health Services (DHS) to discuss the position taken by the DHS relative to the drawing of blood by non-licensed individuals on a mobile basis. The DHS waived certain requirements determined to be not applicable to the paramedical industry and has proposed a type of limited licensure for paramedical companies. The paramedical industry is presently working out the details of such licensure with the DHS and is confident that an agreement on licensure will be reached. The Company continues to service its customers in the State of California without interruption.

In the past, some state agencies have claimed that we improperly classified our examiners as independent contractors for purposes of state unemployment tax laws and that we were therefore liable for taxes in arrears, or for penalties for failure to comply with their interpretation of the laws. We received an adverse determination in the State of California, and as a result, converted our independent contractors to employees. Other similar state claims are also pending. We cannot be assured that we will prevail in these cases, or that we will not be subject to similar claims in other states in the future.

2001 Compared to 2000

Total revenues for 2001 decreased 11% to $245.2 million from $275.0 million for 2000. The number of paramedical examinations performed decreased from 3,414,000 in 2000 to 2,981,000 in 2001, a decrease of 13%. The decrease in the number of paramedical examinations is the result of a slower than expected recovery in the life insurance industry, an increasingly difficult economic environment and certain competitive issues, including the loss of a major customer. The volume decrease in the number of paramedical examinations was partially offset by a slight increase in the average revenue per examination, which is the result of an increase in services performed per examination. The number of Infolink reports decreased 2% to 410,000 for the year 2001, compared to 420,000 for the year 2000. The decrease is the result of decreased volume resulting from a slower than expected recovery in the life insurance industry and an increasingly difficult economic environment. Also, the average price per report decreased approximately 16%, as lower priced reports provided to several major clients represented a greater percentage of the total Infolink reports provided.

The Company’s cost of operations in 2001 totaled $175.3 million compared to $197.3 million for 2000. This reduction is attributable to lower branch operating costs, which were reduced by approximately $3.2 million in 2001 compared to 2000 and is the result of the Company’s efforts to lower its field expenses as revenues declined. As a percentage of revenue, cost of operations improved slightly to 71.5%

Annual Report 2002    15

Hooper Holmes, Inc. and Subsidiaries

for 2001, compared to 71.8% for 2000.

Selling, general and administrative (SG&A) expenses totaled $45.8 million for 2001, compared to $45.0 million for 2000, and as a percentage of revenues totaled 18.7% compared to 16.4%, respectively. The increase, as a percentage of revenues, is due to lower revenue levels in 2001.

Accordingly, the Company’s operating income decreased 26.1% to $24.1 million for 2001 from $32.6 million for 2000, and as a percentage of revenues, decreased to 9.8% compared to 11.9%, respectively.

Interest expense decreased to $0.2 million for 2001, compared to $1.3 million for 2000 as a result of lower borrowings against the Company’s term loan, and lower interest rates. Interest income in 2001 consisted of interest earned on invested funds, the average balance of which was $72.7 million in 2001, compared to $81.7 million in 2000. Interest income decreased to $3.3 million in 2001, compared to $4.3 million in 2000 and is due to lower average invested funds and lower interest rates. Other income (expense) includes a one-time, non-operating provision for legal matters of $1.2 million on a pre-tax basis, or $0.7 million after tax.

The effective tax rate was 41% and 42% in 2001 and 2000, respectively. The decrease is primarily the result of lower state tax rates, and interest earned on tax exempt investments in fiscal 2001.

Net income for 2001 was $15.2 million or $.23 per diluted share versus $21.0 million or $.31 per diluted share for 2000.

Inflation did not have a significant effect on the Company’s operations in 2001.

Liquidity and Financial Resources

The Company’s primary sources of cash are internally generated funds, cash equivalents, marketable securities, and the Company’s credit facility.

For the year ended December 31, 2002, the net cash provided by operating activities was $28.5 million as compared to $33.6 million in 2001. The significant sources were net income of $14.3 million, $5.2 million of depreciation and amortization, a $6.7 million non-cash adjustment related to the write down of the e-Nable investment, and a $2.7 million decrease in accounts receivable partially offset by a decrease in accounts payable and accrued expenses of $1.8 million. The decrease in accounts receivable was due to strong accounts receivable collections in December 2002. Days sales outstanding was 35.7 days at December 31, 2002 (adjusted to include full year pro forma results for the 2002 acquisition of Medicals Direct Group and D&D Associates), compared to 36.5 days at December 31, 2001.

On January 31, 2001, the Company entered into a marketing and equity investment agreement with eNable Corporation (e-Nable), at a total initial cost of $5.0 million. e-Nable Corporation provides Internet-based business processing solutions that allow integration of data sources, underwriting intelligence, distribution channels and insurance products. In August 2001, the Company executed a convertible promissory note agreement with e-Nable to provide additional financing for up to $1.75 million, all of which had been funded by August 2002. The Company has no future obligation or intent to contribute additional funds to e-Nable. Under the cost method of accounting, investments are carried at cost and are adjusted only for other-than-temporary declines in fair value, distributions of earnings and additional investments.

During the second quarter of 2002, the Company recorded a 25% write down to the carrying value of its

16     Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

investment in and advances to e-Nable Corporation, which resulted in a pre-tax charge of $1.6 million, or $1.0 million after tax. The adjustment was estimated based on an assessment of the fair value of the investment and was mainly the result of the difficulty e-Nable had in securing additional financing in the capital markets. During the third quarter of 2002, the Company wrote off the remaining carrying value of its investment in and advances to e-Nable Corporation, which resulted in a pre-tax charge of $5.1 million, or $3.1 million after tax. The adjustment was based on the continuing assessment of the carrying value of the investment, given that e-Nable has been unsuccessful in its attempt to secure additional capital. The Company has no future obligation or intent to fund the operations of e-Nable.

On May 30, 2000, the Board of Directors authorized the repurchase in any calendar year of up to 2.5 million shares of the Company’s common stock for an aggregate purchase price not to exceed $25 million per year. For the years ended December 31, 2002, 2001 and 2000, the Company purchased 1,346,000, 1,347,000 and 1,785,000 shares at a total cost of $8.6 million, $10.8 million and $17.1 million, respectively.

On October 29, 1999, the Company replaced its previous revolving loan facility and entered into a senior credit facility with three banks that included a $65 million, six-year term loan, and a $35 million, three-year revolving loan. During 2001, the three year revolving loan expiration date was extended for one year to October 31, 2003. The loans bear interest at either the prime rate minus ¹/₂% to plus ¹/₄% or LIBOR plus ³/₄% to 1³/₄%, depending on the ratio of our consolidated funded debt, as defined, to our earnings before interest, taxes, depreciation and amortization or “EBITDA” ratio. As of December 31, 2002, interest was payable at an effective interest rate of 2.2% per annum, and the Company had outstanding borrowings against the term loan in the amount of $3 million. There are no additional borrowings available under the original $65 million term loan due to previous borrowings which have been repaid. There are no borrowings against the revolving loan. As of December 31, 2002 and 2001, the majority owned subsidiary of the Company had outstanding obligations under its bank note in the amount of $0.4 million, which was repaid in March 2003.

Our current ratio as of December 31, 2002 was 3.7 to 1, compared to 5.6 to 1 at December 31, 2001. The change in the current ratio is due to reduced cash and marketable securities in 2002, primarily used to fund the acquisitions of D&D Associates and Medicals Direct Group. Also, inflation has not had, nor is it expected to have, a material impact on our consolidated financial results. We have no material commitments for capital expenditures. Quarterly dividends paid in 2002 were $.01 per share, and totaled $2.6 million.

Future payments due under debt and lease obligations as of December 31, 2002 are as follows:

	Credit Facilities		Operating Leases		Total
2003	$	172,776	$	11,177,805	$	11,350,581
2004		1,313,983		7,596,352		8,910,335
2005		1,000,000		2,319,899		3,319,899
2006		1,000,000		528,231		1,528,231
2007		—		295,624		295,624
	$	3,486,759	$	21,917,911	$	25,404,670

Management believes that the combination of current cash, cash equivalents, marketable securities, and available borrowings under our senior credit facility, along with anticipated cash flows from operations, will provide sufficient capital resources to satisfy both our short-term and foreseeable long-term needs.

Annual Report 2002    17

Hooper Holmes, Inc. and Subsidiaries

Critical Accounting Policies

The SEC defines critical accounting policies as those that require application of management’s most difficult, subjective or complex judgements, often as a result of the need to make estimates about the effect of matters that are inherently uncertain and may change in subsequent periods.

The following is not intended to be a comprehensive list of our accounting policies. Our significant accounting policies are more fully described in Note 1 to the Consolidated Financial Statements. In many cases, the accounting treatment of a particular transaction is specifically dictated by accounting principles generally accepted in the United States of America, with no need for management’s judgement in their application. There are also areas in which management’s judgement in selecting an available alternative would not produce a materially different result.

We have identified the following accounting policies as critical to us:

Ÿ Revenue recognition

Ÿ Accounting for income taxes

Ÿ Valuation of long-lived assets

Revenue recognition — The Company recognizes revenues for paramedical and medical examinations when the examination of the insurance policy applicant is completed. Revenue generated from medical record collection, laboratory testing and other services likewise is recognized when the related service is completed. The Company does not record any deferred revenue. The Company does not enter into any multi-element revenue arrangements.

Accounting for income taxes — As part of the process of preparing our consolidated financial statements we are required to estimate our income taxes in each of the jurisdictions in which we operate. This process involves us estimating our actual current tax expense together with assessing temporary differences resulting from differing treatment of items for tax and accounting purposes. These differences result in deferred tax assets and liabilities, which are included within our consolidated balance sheet. We must then assess the likelihood that our deferred tax assets will be recovered from future taxable income and to the extent we believe that recovery is not likely, we must establish a valuation allowance. If the Company was to establish a valuation allowance or increase this allowance in a period, the Company must include an expense within the tax provision in the consolidated statement of income. Significant management judgement is required in determining our provision for income taxes and our deferred tax assets and liabilities.

Valuation of long-lived assets — We assess the impairment of identifiable intangibles, property, plant and equipment, goodwill and investments whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Factors we consider important which could trigger an impairment review include the following:

Ÿ significant underperformance relative to expected historical or projected future operating results;

Ÿ significant changes in the manner of our use of the acquired assets or the strategy for our overall business;

Ÿ significant negative industry or economic trends;

Ÿ significant decline in our stock price for a sustained period; and

Ÿ our market capitalization relative to net book value.

When we determine that the carrying value of intangibles, long-lived assets and related goodwill may

18    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

not be recoverable based upon the existence of one or more of the above indicators of impairment, impairments are recognized when the expected future undiscounted cash flows derived from such assets are less than their carrying value, except for investments. We generally measure any impairment based on a projected discounted cash flow method using a discount rate determined by our management to be commensurate with the risk inherent in our current business model. A loss in the value of an investment will be recognized when it is determined that the decline in value is other than temporary. Net identifiable intangible assets, property, plant and equipment and goodwill amounted to $154.2 million as of December 31, 2002.

On January 1, 2002, the Company adopted Financial Accounting Standards Board (“FASB”), Statement of Financial Accounting Standards (“SFAS”) No. 142, “Goodwill and Other Intangible Assets.” As a result, the Company ceased amortizing approximately $82.7 million of goodwill. We had recorded approximately $3.8 million of amortization on these amounts during 2001 and would have recorded approximately $5.1 million in amortization during 2002. In lieu of amortization, we were required to perform an initial impairment review of our goodwill as of January 1, 2002, and an annual impairment review thereafter. We were not required to record an impairment charge upon completion of our initial impairment review which we performed during the first quarter of 2002. We also were not required to record an impairment charge after completing our December 31, 2002 assessment.

Recently Issued Accounting Standards

In June 2001, the FASB issued SFAS No. 143, “Accounting for Asset Retirement Obligations” (“SFAS No. 143”). SFAS No. 143 requires companies to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. Companies also record a corresponding asset which is depreciated over the life of the asset. Subsequent to the initial measurement of the asset retirement obligation, the obligation will be adjusted at the end of each period to reflect the passage of time and changes in the estimated future cash flows underlying the obligation. The Company is required to adopt SFAS No. 143 on January 1, 2003 and the Company does not anticipate that the statement will have a material impact on the Company’s consolidated financial statements.

In June 2002, the FASB issued SFAS No.146, ”Accounting for Costs Associated with Exit or Disposal Activities”. SFAS 146 nullifies Emerging Issues Task Force (EITF) Issue No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring)” (“EITF 94-3”) and requires that a liability for a cost associated with an exit or disposal activity be recognized and measured initially at fair value in the period in which the liability is incurred. Under EITF 94-3, a liability for an exit cost was recognized at the date of an entity’s commitment to an exit plan. The adoption of SFAS 146 is expected to result in delayed recognition for certain types of costs as compared to the provisions of EITF 94-3. SFAS 146 is effective for new exit or disposal activities that are initiated after December 31, 2002, and does not affect amounts currently reported in the Company’s consolidated financial statements. SFAS 146 will affect the types and timing of costs included in future restructuring programs, if any, but is not expected to have a material impact on the Company’s consolidated financial position or results of operations.

In December 2002, the FASB issued SFAS No. 148, “Accounting for Stock-Based Compensation – Transition and Disclosure, an amendment of FASB Statement No. 123.” This Statement amends FASB

Annual Report 2002    19

Hooper Holmes, Inc. and Subsidiaries

Statement No. 123, Accounting for Stock-Based Compensation, to provide alternative methods of transition for a voluntary change to the fair value method of accounting for stock-based employee compensation. The Company expects to continue to account for stock options under APB No. 25. In addition, this Statement amends the disclosure requirements of Statement No. 123 to require prominent disclosures in both annual and interim financial statements. Certain of the disclosure modifications are required for fiscal years ending after December 15, 2002 and are included in the notes to these consolidated financial statements.

In November 2002, the FASB issued Interpretation No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness to Others, an interpretation of FASB Statements No. 5, 57 and 107 and a rescission of FASB Interpretation No. 34.” This Interpretation elaborates on the disclosures to be made by a guarantor in its interim and annual financial statements about its obligations under guarantees issued. The Interpretation also clarifies that a guarantor is required to recognize, at inception of a guarantee, a liability for the fair value of the obligation undertaken. The initial recognition and measurement provisions of the Interpretation are applicable to guarantees issued or modified after December 31, 2002 and are not expected to have a material effect on the Company’s consolidated financial statements. The disclosure requirements are effective for financial statements of interim or annual periods ending after December 15, 2002.

Quantitative and Qualitative Disclosures About Market Risk

The Company’s exposure to market risk for changes in interest rates relates primarily to the Company’s investment portfolio. The Company places its investments with high quality issuers and, by policy, limits the amount of credit exposure to any one issuer. The Company does not invest in portfolio equity securities or commodities or use financial derivatives for trading purposes. The Company’s debt security portfolio represents funds held temporarily pending use in our business and operations. The Company mitigates its risk by investing in only high credit quality securities that it believes to be low risk and by positioning its portfolio to respond to a significant reduction in a credit rating of any investment issuer or guarantor. The portfolio includes only marketable securities with active secondary or resale markets to insure portfolio liquidity.

The table below presents the principal amounts and related weighted average interest rates by year of maturity for our investment portfolio as of December 31, 2002.

(in thousands)	2003		2004		2005		2006		2007		2008 and Thereafter		Total		Estimated Fair Value
Fixed rate investments	$	6,296	$	10,321	$	2,367	$	2,470	$	150	$	500	$	22,104	$	22,761
Average interest rates		3.77%		4.16%		4.27%		3.73%		6.66%		5.09%		4.05%

The Company is exposed to market risk from changes in interest rates which may adversely affect its financial position, results of operations and cash flows. The Company is exposed to interest rate risk primarily through its borrowing activities, which are described in Note 7 to the Consolidated Financial Statements. The Company’s borrowings are under variable rate instruments. Future payments due under borrowings are $172,776 in 2003, $1,313,983 in 2004, and $1,000,000 in 2005 and 2006, at an average interest rate of 3.7%.

Based on the Company’s market risk sensitive instruments (including investments and variable rate debt) outstanding at December 31, 2002, the Company has determined that there was no material market risk

20    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

exposure to the Company’s consolidated financial position, results of operations or cash flows as of such date.

Forward Looking Statements

Certain written and oral statements made by our Company or with the approval of an authorized executive officer of our Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995, including statements made in this report and other filings with the Securities and Exchange Commission. These statements generally are not historical in nature and can be identified by words such as “believe,” “expect,” “intend,” “estimate,” “anticipate,” “project,” “will,” “may,” “should,” “could” and similar expressions. These statements involve risks and uncertainties that could cause actual results to differ materially from our Company’s historical experience and our present expectations or projections. These statements are not guarantees of future performance or results.

The following are some of the factors that could cause our Company’s actual results to differ materially from those described in forward-looking statements:

Trends and other developments affecting the life insurance industry—We currently derive nearly all of our revenues from life insurance companies. The demand for our services is largely dependent on the demand for life insurance policies, policy amounts, the type of health information services requested, general economic conditions, and other factors beyond our control. Any decreases in demand for health information services by life insurance companies could substantially harm our business.

Loss of customers—Our relationships with most insurance company customers are not covered by formal written agreements, and we have exclusive relationships with only a small number of customers. Our ability to retain these customers will depend on our continued ability to serve their needs and distinguish us from our competitors. The loss of one or more customers could materially impact our business.

Changes in the health information services business environment—These include changes in the types of products demanded by insurance companies, competitive product and pricing pressures, including technological advancements by competitors, and our ability to gain or maintain market share notwithstanding the actions of our competitors. Factors such as these could impact our earnings and growth.

Continued growth of alternative distribution channels—Our continued growth will depend in part on increased use of the Internet and other alternative distribution channels by our customers to sell their life insurance products. Rapid growth in the use of these distribution channels may not continue. Reduction or replacement of these channels could limit any growth in the number of applications for life insurance policies, which could substantially harm our business.

Need to enhance and expand our technology and infrastructure—We need to continually adapt to the technological needs of our insurance company customers by enhancing and expanding our technology and network infrastructure to accommodate our customers’ changing needs. Our failure to do so could substantially harm our business.

Loss of key management—Our continued success is materially dependent upon our key management team, including James M. McNamee, our Chairman, President and Chief Executive Officer, none of whom has an employment agreement. If we lose one or more of our executive officers, an inability to successfully recruit and retain additional highly skilled and experienced management, or to successfully train and promote existing personnel to serve in a managerial capacity, could substantially harm our business.

Annual Report 2002    21

Hooper Holmes, Inc. and Subsidiaries

Acquisitions and other strategic investments—Our growth strategy has included acquiring other businesses and making strategic investments. There is no guarantee that these activities will be profitable, or that we will continue growing through these types of activities or otherwise.

Changes in laws and regulations, including changes in accounting standards, taxation requirements and environmental laws.

The effectiveness of our sales, advertising and marketing programs.

Our ability to achieve earnings forecasts, which are primarily based on projected numbers of examinations to be performed.

Economic and political conditions in the United States.

The uncertainties of litigation, as well as other risks and uncertainties detailed from time to time in our Securities and Exchange Commission filings.

Other factors not identified could also cause actual results to materially differ from those described in forward-looking statements. Caution should be taken not to place undue reliance on any forward-looking statements made in this report or otherwise since such statements speak only as of the date when made. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

22    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Consolidated Balance Sheets

	December 31,
	2002		2001
Assets
Current assets:
Cash and cash equivalents	$	23,298,151	$	52,571,616
Marketable securities		22,761,101		31,225,891
Accounts receivable, net		27,809,521		24,939,364
Other current assets		6,823,818		5,676,399
Total current assets		80,692,591		114,413,270
Property, plant and equipment		30,620,147		28,188,908
Less: Accumulated depreciation and amortization		21,924,363		20,355,456
		8,695,784		7,833,452
Goodwill		117,075,544		81,515,202
Intangible assets		28,474,439		11,995,686
Investment in e-Nable Corporation		—		5,218,750
Other assets		1,291,172		994,383
	$	236,229,530	$	221,970,743
Liabilities and Stockholders’ Equity
Current liabilities:
Current maturities of long-term debt	$	172,776	$	239,669
Accounts payable		10,436,388		7,479,797
Accrued expenses:
Insurance benefits		484,748		386,093
Salaries, wages and fees		1,816,791		3,368,318
Payroll and other taxes		449,093		289,779
Income taxes payable		2,703,713		4,683,762
Other		5,853,132		3,906,662
Total current liabilities		21,916,641		20,354,080
Long-term debt, less current maturities		3,313,983		3,280,496
Other long-term liabilities		806,195		—
Deferred income taxes		3,483,114		1,741,617
Minority interest		902,650		187,676
Commitments and contingencies
Stockholders’ equity:
Common stock, par value $.04 per share; authorized 240,000,000 shares, issued 67,499,074 in 2002 and 2001		2,699,963		2,699,963
Additional paid-in capital		128,079,363		134,482,010
Accumulated other comprehensive income		160,873		201,589
Retained earnings		96,009,551		84,308,815
		226,949,750		221,692,377
Less: Treasury stock at cost (2,754,151 shares in 2002 and 2,949,459 shares in 2001)		21,142,803		25,285,503
Total stockholders’ equity		205,806,947		196,406,874
	$	236,229,530	$	221,970,743

See accompanying notes to consolidated financial statements.

Annual Report 2002    23

Hooper Holmes, Inc. and Subsidiaries

Consolidated Statements of Income

	Years ended December 31,
	2002			2001			2000
Revenues	$	260,317,046		$	245,184,854		$	274,973,666
Cost of operations		185,760,136			175,281,461			197,347,143
Gross profit		74,556,910			69,903,393			77,626,523
Selling, general and administrative expenses		45,935,249			45,792,053			44,993,468
Loss on investment		6,750,000			—			—
Operating income		21,871,661			24,111,340			32,633,055
Other income (expense):
Interest expense		(112,841	)		(204,109	)		(1,290,973	)
Interest income		2,308,971			3,289,982			4,259,390
Other (expense) income, net		(619,553	)		(1,273,308	)		532,379
		1,576,577			1,812,565			3,500,796
Income before income taxes		23,448,238			25,923,905			36,133,851
Income taxes		9,155,695			10,677,000			15,170,000
Net income	$	14,292,543		$	15,246,905		$	20,963,851
Earnings per share:
Basic	$	.22		$	.24		$	.32
Diluted	$	.21		$	.23		$	.31
Weighted average shares — basic		64,868,163			64,895,764			64,830,697
Weighted average shares — diluted		67,229,119			67,618,151			68,377,742

Per share and share amounts are adjusted to reflect a two for one stock split effective April 12, 2000.

See accompanying notes to consolidated financial statements.

24    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Consolidated Statements of Stockholders’ Equity

	Common Stock			Additional Paid-in Capital			Accumulated Other Com-  prehensive Income		Retained Earnings			Treasury Stock			Total
	Number of Shares	Amount
Balance, December 31, 1999	58,391,052	$	2,335,642	$	36,357,092		$       —		$	51,971,602		$	(972,640	)	$	89,691,696
Net income										20,963,851						20,963,851
Cash dividends ($.030 per share)										(1,925,458	)					(1,925,458	)
Net proceeds from the sale of common stock	7,350,000		294,000		86,534,696											86,828,696
Issuance of stock award	10,000		400		153,350											153,750
Exercise of stock options	1,589,000		63,560		3,637,884											3,701,444
Exercised stock option tax benefit					8,060,000											8,060,000
Issuance of shares for employee stock purchase plan	114,122		4,565		676,173											680,738
Purchase of treasury stock													(17,078,096	)		(17,078,096	)
Balance, December 31, 2000	67,454,174		2,698,167		135,419,195		—			71,009,995			(18,050,736	)		191,076,621
Net income										15,246,905						15,246,905
Cash dividends ($.030 per share)										(1,948,085	)					(1,948,085	)
Unrealized gains on marketable securities, net of tax							201,589									201,589
Issuance of stock award					5,689								46,311			52,000
Exercise of stock options	44,900		1,796		(2,118,974	)							3,060,551			943,373
Exercised stock option tax benefit					1,131,249											1,131,249
Issuance of shares for acquisitions					44,851								455,150			500,001
Purchase of treasury stock													(10,796,779	)		(10,796,779	)
Balance, December 31, 2001	67,499,074		2,699,963		134,482,010		201,589			84,308,815			(25,285,503	)		196,406,874
Net income										14,292,543						14,292,543
Cash dividends ($.040 per share)										(2,591,807	)					(2,591,807	)
Unrealized gains (loss) on marketable securities, net of tax							(74,543	)								(74,543	)
Foreign currency translation							33,827									33,827
Exercise of stock options					(9,515,005	)							12,074,862			2,559,857
Exercised stock option tax benefit					3,183,000											3,183,000
Issuance of shares for employee stock purchase plan					(70,642	)							622,463			551,821
Purchase of treasury stock													(8,554,625	)		(8,554,625	)
Balance, December 31, 2002	67,499,074	$	2,699,963	$	128,079,363		$160,873		$	96,009,551		$	(21,142,803	)	$	205,806,947

Per share amounts are adjusted to reflect a two for one stock split effective April 12, 2000.

See accompanying notes to consolidated financial statements.

Annual Report 2002    25

Hooper Holmes, Inc. and Subsidiaries

Consolidated Statements of Cash Flows

	Years ended December 31,
	2002			2001			2000
Cash flows from operating activities:
Net income	$	14,292,543		$	15,246,905		$	20,963,851
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		5,213,731			9,288,418			9,003,473
Loss on investment		6,750,000
Provision for bad debt expense		175,000			233,499			—
Deferred tax expense (benefit)		1,219,000			(720,000	)		918,587
Net realized loss (gain) on sale of marketable securities		188,227			(228,989	)		(168,049	)
Issuance of stock awards		—			52,000			153,750
Loss on sale of fixed assets		112,737			41,613			50,873
Change in assets and liabilities, net of effect from acquisitions of businesses:
Accounts receivable		2,677,633			3,697,761			8,307,328
Other assets		(1,039,922	)		(1,380,324	)		(1,874,676	)
Accounts payable and accrued expenses		(1,762,723	)		7,327,823			(3,912,756	)
Net cash provided by operating activities		27,826,226			33,558,706			33,442,381
Cash flows from investing activities:
Business acquisitions, net of cash acquired		(53,465,496	)		(7,282,389	)		(8,728,550	)
Purchases of marketable securities		(33,749,818	)		(30,049,331	)		(79,507,324	)
Redemptions of marketable securities		41,951,838			28,442,327			50,319,015
Investment in e-Nable Corporation		(1,531,250	)		(5,218,750	)		—
Capital expenditures, net of disposals		(2,141,267	)		(885,961	)		(1,357,525	)
Net cash used in investing activities		(48,935,993	)		(14,994,104	)		(39,274,384	)
Cash flows from financing activities:
Issuance of long-term debt		—			250,000			100,000
Principal payments on long-term debt		(119,889	)		(121,966	)		(62,157,869	)
Proceeds from issuance of common stock		—			—			86,828,696
Proceeds from employee stock purchase plan		551,821			—			680,738
Proceeds related to the exercise of stock options		2,559,857			943,373			3,701,444
Treasury stock acquired		(8,554,625	)		(10,796,779	)		(17,078,096	)
Dividends paid		(2,591,807	)		(1,948,085	)		(1,925,458	)
Net cash (used in) provided by financing activities		(8,154,643	)		(11,673,457	)		10,149,455
Effect of exchange rate changes on cash		(9,055	)		—			—
Net (decrease) increase in cash and cash equivalents		(29,273,465	)		6,891,145			4,317,452
Cash and cash equivalents at beginning of year		52,571,616			45,680,471			41,363,019
Cash and cash equivalents at end of year	$	23,298,151		$	52,571,616		$	45,680,471
Supplemental disclosure of non-cash investing activity:
Change in net unrealized gain on marketable securities available for sale	$	17,800		$	201,589		$	—
Common stock issued for business acquisitions	$	—		$	500,001		$	—
Supplemental disclosure of cash flow information:
Cash paid during the year for:
Interest	$	286,139		$	213,310		$	2,065,297
Income taxes	$	7,418,690		$	7,925,370		$	9,883,975

See accompanying notes to consolidated financial statements.

26     Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Notes to Consolidated Financial Statements

Note 1 — Summary of Significant Accounting Policies

Principles of Consolidation

The consolidated financial statements include the accounts of Hooper Holmes, Inc. and its majority owned subsidiaries (the “Company”). The Company’s investment in e-Nable Corporation, which was written off in 2002, was accounted for by the cost method based on the percentage of common ownership being less than 20% and the Company’s inability to exercise significant influence (see Note 6). All significant intercompany balances and transactions are eliminated in consolidation.

Description of the Business

The Company provides health information services to the life and health insurance industry. The Company’s network of experienced medical professionals conduct physical examinations, laboratory testing, personal health interviews, and independent medical examinations primarily for the life and health and automobile insurance industries. Information gathered in these activities is used by insurance underwriters and claims managers to assess risks and make informed decisions. The Company is subject to certain risks and uncertainties as a result of changes that could occur in the life and health insurance industry’s underwriting requirements and standards, in the automobile insurance industry, and in the Company’s customer base.

Foreign Currency

The financial statements of the foreign subsidiary are translated into United States dollars at current year-end rates, except that the revenues, costs and expenses are translated at average monthly rates during each monthly period. Net exchange gains or losses resulting from the translation of foreign financial statements and the effect of exchange rate changes on intercompany transactions of a long-term investment nature are accumulated and credited or charged directly to a separate component of accumulated other comprehensive income. Any foreign currency gains or losses related to transactions are charged to other (income) expense, net.

Use of Estimates

The preparation of the consolidated financial statements requires management to make estimates and assumptions that affect reported amounts and disclosures in these consolidated financial statements. Some of the significant estimates involve the evaluation of the recoverability of long-lived assets and the assessment of contingencies including income taxes. Actual results could differ from those estimates.

Marketable Securities

At December 31, 2002 and 2001, marketable securities consist of U.S. Treasury, mortgage-backed, asset-backed and corporate debt securities and bank certificates of deposit. The Company classifies all of its marketable security investments as available-for-sale. Available-for-sale securities are recorded at fair value and dividend and interest income are recognized when earned. Unrealized holding gains and losses, net of the related tax

Annual Report 2002    27

Hooper Holmes, Inc. and Subsidiaries

effect, on available-for-sale securities are excluded from earnings and are reported as a separate component of other comprehensive income until realized. Realized gains and losses from the sale of available-for-sale securities are determined on a specific identification basis. A decline in the market value of any available-for-sale security below cost that is deemed to be other than temporary results in a reduction in carrying amount to fair value. The impairment is charged to earnings and a new cost basis for the security is established. Premiums and discounts are amortized or accreted over the life of the related available-for-sale security as an adjustment to yield using the effective interest method.

Cash and Cash Equivalents

The Company considers highly liquid investments with original maturities at the date of purchase of less than 90 days to be cash equivalents.

Property, Plant and Equipment

Property, plant and equipment are carried at cost. Depreciation is computed using the straight-line method over the assets estimated useful lives. The cost of maintenance and repairs is charged to income as incurred. Significant renewals and betterments are capitalized.

Impairment of Long Lived Assets

The Company reviews long-lived assets for impairment whenever events or changes in business circumstances occur that indicate that the carrying amount of the assets may not be recoverable. Impairments are recognized when the expected future undiscounted cash flows derived from such assets are less than their carrying value, except for investments. A loss in the value of an investment will be recognized when it is determined that the decline in value is other than temporary. For such cases, losses are recognized for the difference between the fair value and the carrying amount. The Company considers various valuation factors, principally discounted cash flows, to assess the fair values of long-lived assets.

Goodwill and intangible assets not subject to amortization are tested annually for impairment, and are tested for impairment more frequently if events and circumstances indicate that the asset might be impaired. An impairment loss is recognized to the extent that the carrying amount exceeds the asset’s fair value.

Goodwill and Other Acquisition Intangibles

Goodwill represents the excess of acquisition costs over the fair value of net assets of acquired businesses. The Company adopted the provisions of SFAS 142 as of January 1, 2002. Goodwill is not amortized but is reviewed for impairment at least annually and written down only in the periods in which it is determined that the recorded value is greater than the fair value in accordance with the provisions of SFAS 142. For the purposes of performing this impairment test, up until the D&D acquisition on October 31, 2002 (See Note 2), the Company’s one business segment was its reporting unit. The fair value of that reporting unit is compared to its recorded value. If recorded values are less than the fair values, no impairment is indicated. Beginning January 1, 2003, D&D Associates will be a separate business segment and therefore, a separate reporting unit for purposes of future impairment testing. Intangible assets with determinable useful

28    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

lives are amortized over their respective estimated useful lives and reviewed for impairment when events or changes in circumstances indicate that the carrying value may not be recoverable. Goodwill and intangible assets acquired in business combinations completed before June 30, 2001, had been amortized through December 31, 2001, in accordance with generally accepted accounting principles prior to the issuance of Statement of Financial Accounting Standards (“SFAS”) No. 141, “Business Combinations” (“SFAS 141”) and SFAS No. 142, “Goodwill and Other Intangible Assets” (“SFAS 142”).

Comprehensive Income

The Company follows SFAS No. 130, “Reporting Comprehensive Income,” which establishes standards for reporting and presentation of comprehensive income and its components in a full set of financial statements. Comprehensive income consists of net income, unrealized gains (losses) on marketable securities and foreign currency translation. Total comprehensive income for the years ended December 31, 2002, 2001 and 2000, totaled $14,251,827, $15,448,494 and $20,793,257, respectively. Accumulated other comprehensive income as reported in the accompanying balance sheet, consists of $33,827 of foreign currency translation adjustments and $127,046 of unrealized gains (net of tax of $92,343) at December 31, 2002.

Earnings Per Common Share

“Basic” earnings per common share equals net income divided by the weighted average common shares outstanding during the period. “Diluted” earnings per common share equals net income divided by the sum of the weighted average common shares outstanding during the period plus common stock equivalents. Common stock equivalents (2,360,956, 2,722,387 and 3,547,045 for 2002, 2001 and 2000, respectively) are shares assumed to be issued if outstanding stock options were exercised. All appropriate share and per share period amounts have been restated for the April 12, 2000 stock split (see note 11, “Capital Stock”).

Revenues

The Company recognizes revenues for paramedical and medical examinations when the examination of the insurance policy applicant is completed. Revenue generated from medical record collection, laboratory testing and other services is recognized when the related service is completed. The Company does not record any deferred revenue. The Company does not enter into any multi-element revenue arrangements.

Income Taxes

Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

No provision has been made for federal income or withholding taxes which may be payable on the remittance of the undistributed retained earnings of foreign subsidiaries. These earnings have been reinvested to meet future operating requirements and the Company intends to continue such policy for the foreseeable future.

Annual Report 2002    29

Hooper Holmes, Inc. and Subsidiaries

Concentration of Credit Risk

The Company’s accounts receivable are due primarily from insurance companies. No one customer accounts for more than 10% of revenues.

Fair Value of Financial Instruments

The carrying value for all financial instruments, except marketable securities and long-term debt, at December 31, 2002 and 2001, approximates fair value due to the short maturity of these instruments. The fair value of marketable securities is determined using quoted market prices for these securities. For long-term debt, the carrying value approximates fair value due to the interest rate being reset in December 2002.

Stock-Based Compensation

At December 31, 2002, the Company has stock-based employee compensation plans, which are described more fully in Note 12. The Company accounts for those plans under the recognition and measurement principles of Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees,” and related Interpretations. No stock-based compensation cost is reflected in net income for stock options, as all options granted under those plans had an exercise price equal to the market value of the underlying common stock on the date of the grant. The following table illustrates the effect on net income and earnings per share if the Company had applied the fair value recognition provisions of SFAS No. 123, “Accounting for Stock-Based Compensation” (“SFAS 123”) to stock-based employee compensation:

(thousands of dollars, except per share data)	2002		2001		2000
Net earnings, as reported	$	14,293	$	15,247	$	20,964
Deduct: Total stock-based employee compensation expense determined under fair value based method for all awards, net of related tax effects		3,376		2,785		3,091
Pro forma net earnings	$	10,917	$	12,462	$	17,873
Earnings per share:
Basic, as reported	$	.22	$	.24	$	.32
Basic, pro forma		.17		.19		.28
Diluted, as reported	$	.21	$	.23	$	.31
Diluted, pro forma		.16		.18		.26

The fair value of each stock option granted during the year is estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions:

	2002		2001		2000
Expected life (years)		8.3		9.3		9.6
Expected volatility		48.04%		44.78%		43.78%
Expected dividend yield		.57%		.37%		.26%
Risk-free interest rate		1.75%		3.25%		5.75%
Weighted average fair value of options granted during the year	$	3.28	$	4.50	$	4.36

30    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Advertising

Costs related to space in publications are expensed the first time the advertising occurs. Advertising expense was approximately $306,000, $299,000 and $289,000 in 2002, 2001 and 2000, respectively.

Recently Issued Accounting Standards

In June 2001, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 143, Accounting for Asset Retirement Obligations (“SFAS No. 143”). SFAS No. 143 requires companies to record the fair value of an asset retirement obligation as a liability in the period in which it incurs a legal obligation associated with the retirement of tangible long-lived assets that result from the acquisition, construction, development and/or normal use of the assets. Companies also record a corresponding asset which is depreciated over the life of the asset. Subsequent to the initial measurement of the asset retirement obligation, the obligation will be adjusted at the end of each period to reflect the passage of time and changes in the estimated future cash flows underlying the obligation. The Company is required to adopt SFAS No. 143 on January 1, 2003 and the Company does not anticipate that the statement will have a material impact on the Company’s consolidated financial statements.

In June 2002, the FASB issued SFAS No. 146, “Accounting for Costs Associated with Exit or Disposal Activities”. SFAS 146 nullifies Emerging Issues Task Force (EITF) Issue No. 94-3, “Liability Recognition for Certain Employee Termination Benefits and Other Costs to Exit an Activity (including Certain Costs Incurred in a Restructuring)” (“EITF 94-3”) and requires that a liability for a cost associated with an exit or disposal activity be recognized and measured initially at fair value in the period in which the liability is incurred. Under EITF 94-3, a liability for an exit cost was recognized at the date of an entity’s commitment to an exit plan. The adoption of SFAS 146 is expected to result in delayed recognition for certain types of costs as compared to the provisions of EITF 94-3. SFAS 146 is effective for new exit or disposal activities that are initiated after December 31, 2002, and does not affect amounts currently reported in the Company’s consolidated financial statements. SFAS 146 will affect the types and timing of costs included in future restructuring programs, if any.

In December 2002, the FASB issued SFAS No. 148, “Accounting for Stock-Based Compensation – Transition and Disclosure, an amendment of FASB Statement No. 123.” This Statement amends FASB Statement No. 123, “Accounting for Stock-Based Compensation,” to provide alternative methods of transition for a voluntary change to the fair value method of accounting for stock-based employee compensation. The Company expects to continue to account for stock options under APB No. 25. In addition, this Statement amends the disclosure requirements of Statement No. 123 to require prominent disclosures in both annual and interim financial statements. Certain of the disclosure modifications are required for fiscal years ending after December 15, 2002 and are included in the notes to these consolidated financial statements.

In November 2002, the FASB issued Interpretation No. 45, “Guarantor’s Accounting and Disclosure Requirements for Guarantees, Including Indirect Guarantees of Indebtedness to Others, an interpretation of FASB Statements No. 5, 57 and 107 and a rescission of

Annual Report 2002    31

Hooper Holmes, Inc. and Subsidiaries

FASB Interpretation No. 34.” This Interpretation elaborates on the disclosures to be made by a guarantor in its interim and annual financial statements about its obligations under guarantees issued. The Interpretation also clarifies that a guarantor is required to recognize, at inception of a guarantee, a liability for the fair value of the obligation undertaken. The initial recognition and measurement provisions of the Interpretation are applicable to guarantees issued or modified after December 31, 2002 and are not expected to have a material effect on the Company’s financial statements. The disclosure requirements are effective for financial statements of interim or annual periods ending after December 15, 2002.

Note 2 — Acquisitions and Dispositions

On August 15, 2002, the Company acquired all of the outstanding common shares of Medicals Direct Group, located in the United Kingdom. Medicals Direct Group provides paramedical examinations and underwriting services to the life insurance industry, medical services through company operated clinics and medical reports to the legal profession. This acquisition affords the Company the opportunity to enter the U.K. insurance market and to leverage Medicals Direct to expand into insurance markets throughout Europe. The purchase price paid at closing was approximately $7.5 million plus estimated acquisition related costs of approximately $.6 million. In accordance with the purchase agreement, the Company will make an additional payment to certain Medicals Direct Group shareholders during the first quarter of 2004 for approximately $.7 million, and another performance contingency payment, if certain conditions are met, during the second quarter of 2004, for approximately $.8 million. The Company has accrued, in Accrued Expenses “Other”, with a charge to goodwill, these payments at December 31, 2002, as the contingent payments were deemed to be probable of being paid. The Company has recorded goodwill in the amount of $9.6 million and identifiable intangible assets in the amount of $1.0 million. Identifiable intangible assets consist of Customer Base of $.8 million and Tradename of $.2 million with weighted average useful lives of 9 and 10 years, respectively. The goodwill is not deductible for tax purposes. In accordance with SFAS No. 142, which the Company adopted on January 1, 2002, goodwill is no longer amortized.

On October 31, 2002, the Company acquired all of the issued and outstanding common stock of “684” Associates, Ltd., doing business as D&D Associates. D&D is a New York based independent medical examinations (IME) company which provides case management services primarily to property and casualty insurance companies in the New York City metropolitan area. This acquisition has allowed the Company to enter the IME market and is consistent with the Company’s strategy of acquiring businesses in growth areas that complement our core health information business. The purchase price was $38 million plus estimated acquisition related costs of approximately $1.0 million, and was funded from the Company’s existing cash. Additionally, if certain performance criteria are met as outlined in the Stock Purchase Agreement, the Company may be required to pay an additional $1 to $3 million, payable by December 31, 2003. These potential costs are not accrued at December 31, 2002 as payment is not yet probable. If payments are made in the future, they will be recorded as additional goodwill. As a result of an independent third party valuation, the Company has recorded goodwill in the amount

32    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

of $18.6 million, and intangible assets in the amount of $18.2 million. The Goodwill is expected to be deductible for tax purposes. Identifiable intangible assets are comprised of Customer Relationships $15.0 million, Tradename $2.0 million, Physicians Network $.4 million, and a Non-Competition agreement valued at $.8 million and are being amortized over their useful lives of 15 years, 20 years, 10 years and 5 years, respectively. In accordance with SFAS 142, which the Company adopted on January 1, 2002, goodwill is no longer amortized. Revenues and operating income recorded by the Company since the closing of the acquisition totaled $5.1 million and $1.1 million, respectively.

The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisitions:

(in thousands)	Medicals Direct Group As of August 15, 2002	D&D Associates As of October 31, 2002
Cash	$      952	$      657
Accounts receivable	2,479	3,244
Other assets	346	87
Property, plant and equipment	590	451
Intangible assets	950	18,220
Goodwill	9,622	18,626
Total assets acquired	$14,939	$41,285
Current liabilities	$  3,632	$  2,265
Deferred taxes	379	—
Long term debt	87	—
Other long term liabilities	1,234	—
Total liabilities acquired	$  5,332	$  2,265
Net assets acquired	$  9,607	$39,020

The acquisitions discussed above have been accounted for using the purchase method of accounting and the purchase price of the acquisitions has been assigned to the net assets based on the fair value of such assets and liabilities at the date of acquisition. The consolidated financial statements include the results of operations from the respective dates of purchase. The following unaudited pro forma information has been prepared as if the acquisitions of Medicals Direct Group and D&D Associates had occurred on January 1, 2001. The unaudited pro forma financial information does not purport to represent our consolidated results of operations or financial position that would have been achieved had the transactions to which pro forma effect is given been consummated as of the dates or for the periods indicated.

(in thousands, except per share data)	2002		2001
Revenues	$	292,323	$	274,921
Net income		16,481		15,833
Earnings per share – Basic	$	.25	$	.24
Earnings per share – Diluted	$	.25	$	.23

During 2002, the Company acquired specific assets and liabilities of ten health information services companies. The aggregate purchase price of these acquisitions was

Annual Report 2002    33

Hooper Holmes, Inc. and Subsidiaries

approximately $7.5 million plus acquisition related costs of approximately $.1 million, and has resulted in total costs in excess of net assets acquired of $6.5 million, identifiable intangible assets of $.5 million, and non-competition agreements of approximately $.6 million. Identifiable intangible assets and the non-competition agreements are being amortized on a straight line basis over a period of 3 to 9 years. In accordance with SFAS No. 142, which the Company adopted on January 1, 2002, goodwill is no longer amortized. The 2002 health information acquisitions do not require pro forma information, as the results of operations of the businesses acquired were not material.

During 2001, the Company acquired specific assets and liabilities of twelve health information services companies. The aggregate purchase price of these acquisitions was approximately $6.8 million and has resulted in total costs in excess of net assets acquired of approximately $6.0 million. Of the $6.0 million costs in excess of net assets acquired, $4.3 million related to acquisitions prior to June 30, 2001, which is the date the Company adopted FASB Statement No. 141, “Business Combinations,” and are being amortized on a straight line basis over a period of 10 to 25 years. The costs in excess of net assets acquired for acquisitions subsequent to June 30, 2001, were not amortized. Additionally, non-competition agreements were entered into in the aggregate amount of approximately $0.8 million and are being amortized on a straight line basis over 3 to 5 years.

During 2000, the Company acquired specific assets and liabilities of eight health information services companies. The aggregate purchase price of these acquisitions was approximately $10.5 million and has resulted in total costs in excess of net assets acquired of approximately $9.5 million. This amount is being amortized on a straight line basis over a period of 10 to 25 years. Additionally, non-competition agreements were entered into in the aggregate amount of approximately $0.6 million and are being amortized on a straight line basis over 5 years. In accordance with an acquisition agreement, the Company paid an additional $0.4 million as a result of the acquired entity achieving targeted operational results.

34    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Note 3 — Marketable Securities

The amortized cost, gross unrealized holding gains, gross unrealized holding losses and fair value of available-for-sale securities by major security type at December 31, 2002 and 2001, were as follows:

	Amortized Cost		Gross Unrealized Holding Gains	Gross Unrealized Holding Losses		Fair Value
At December 31, 2002
Bank certificates of deposit	$	590,000	$            0	$         0		$	590,000
Government agencies		3,295,847	12,082	0			3,307,929
Government bonds and notes		5,080,240	35,244	0			5,115,484
Corporate debt securities		13,575,625	173,021	(958	)		13,747,688
	$	22,541,712	$220,347	$   (958	)	$	22,761,101
At December 31, 2001
Bank certificates of deposit	$	0	$            0	$         0		$	0
Government agencies		1,915,840	6,001	0			1,921,841
Government bonds and notes		2,149,010	8,390	(2,048	)		2,155,352
Corporate debt securities		26,959,452	194,617	(5,371	)		27,148,698
	$	31,024,302	$209,008	$(7,419	)	$	31,225,891

Maturities of debt securities classified as available-for-sale were as follows at December 31, 2002 (maturities of mortgage-backed securities and collateralized mortgage obligations have been presented based upon estimated cash flows, assuming no change in the current interest rate environment):

	Amortized Cost	Fair Value
Due within one year	$  6,374,630	$  6,396,222
Due after one year through five years	15,650,222	15,839,279
Due after five years through ten years	516,861	525,600
	$22,541,713	$22,761,101

Proceeds from the sale of investment securities available for sale were $41,951,838 and $28,442,327 in 2002 and 2001, respectively, gross realized gains included in income in 2002 and 2001 were $230,172 and $230,735, respectively, and gross realized losses included in income in 2002 and 2001 were $41,945 and $1,746, respectively.

Note 4 — Accounts Receivable

Accounts receivable are net of an allowance for doubtful accounts in the amount of $1,020,569, and $933,961 in 2002 and 2001, respectively.

Annual Report 2002    35

Hooper Holmes, Inc. and Subsidiaries

Note 5 — Property, Plant and Equipment

Property, plant and equipment, at cost, consists of the following:

	December 31, 2002	December 31, 2001	Estimated Useful Life In Years
Land and improvements	$      627,672	$      618,972	10 - 20
Building and improvements	5,546,082	5,062,042	10 - 45
Furniture, fixtures and equipment	24,446,393	22,507,894	3 - 10
	$30,620,147	$28,188,908

Note 6 — Investment

On January 31, 2001, the Company entered into a marketing and equity investment agreement with e-Nable Corporation (e-Nable), at a total original cost of $5.0 million. e-Nable Corporation provides Internet-based business processing solutions that allow integration of data sources, underwriting intelligence, distribution channels and insurance products. In August 2001, the Company executed a convertible promissory note agreement with e-Nable Corporation, to provide additional financing for up to $1.75 million of which $0.2 million was outstanding as of December 31, 2001. The Company has no future commitment to contribute additional funds to e-Nable Corporation other than the additional financing referred to above. Under the cost method of accounting, investments are carried at cost and are adjusted only for other-than-temporary declines in fair value, distributions of earnings and additional investments.

During the second quarter of 2002, the Company recorded a 25% write down of the carrying value of its investment in and advances to e-Nable Corporation, which resulted in a pre-tax charge of $1.6 million, or $1.0 million after tax. The adjustment was estimated based on an assessment of the fair value of the investment and was primarily the result of the difficulty e-Nable was having in securing additional financing in the capital markets. During the third quarter of 2002, the Company wrote off the entire remaining carrying value of its investment in and advances to e-Nable Corporation, which resulted in a pre-tax charge of $5.1 million, or $3.1 million after tax. The adjustment was based on the Company’s conclusion that the decrease in the fair value of the investment was other than temporary, given that e-Nable has been unsuccessful in its attempt to secure additional capital. The Company has no future obligation or intent to fund the operations of e-Nable.

Note 7 — Long Term Debt

On October 29, 1999, the Company entered into a $100 million Amended and Restated Revolving Credit and Term Loan Agreement with three banks. This senior credit facility consists of a $65 million, six-year term loan, and a $35 million, three-year revolving loan. During 2001, the three year revolving loan expiration date was extended for one year to October 31, 2003. The $65 million term loan was used in connection with the purchase of the assets of PSA. There are no additional borrowings available under the original $65 million term loan due to previous borrowings which have been repaid. There are no borrowings against the revolving loan. As of December 31, 2002, $3.0 million is outstanding against the term loan. The Company has not borrowed under the $35 million revolving loan.

36    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Both the term loan and the revolving loan bear interest at either the prime rate minus ¹/₂% to plus ¹/₄% or LIBOR plus ³/₄% to 1³/₄%, depending on the ratio of our consolidated funded debt, as defined, to earnings before interest, taxes, depreciation and amortization, or “EBITDA.” As of December 31, 2002, interest was payable at an effective annual interest rate of 2.20%. Either loan can be prepaid without penalty at any time. Also, commitment fees of up to ¹/₄% of the unused revolving loan are charged, and the agreement contains certain financial covenants related to dividends, fixed charge coverage and funded debt to “EBITDA” ratio.

As of December 31, 2002 and 2001, Heritage Labs, a majority owned subsidiary of the Company, had outstanding obligations under its bank note in the amount of $0.4 million, which was repaid in March 2003. The interest rate at December 31, 2002 and 2001 was 5.25% and 5.75%, respectively.

Note 8 — Commitments and Contingencies

The Company leases branch field offices under a number of operating leases which expire in various years through 2007. These leases generally contain renewal options and require the Company to pay all executory costs (such as property taxes, maintenance and insurance). The Company also leases telephone, computer and other miscellaneous equipment. These leases also expire in various years through 2007. The following is a schedule of future minimum lease payments for operating leases (with initial or remaining terms in excess of one year) as of December 31, 2002:

Year Ending December 31,
2003	$11,177,805
2004	7,596,352
2005	2,319,899
2006	528,231
2007	295,624
Total minimum lease payments	$21,917,911

Rental expense under operating leases aggregated $13,786,642, $12,739,549 and $12,429,976 in 2002, 2001 and 2000, respectively.

The Company has employment retention contracts with certain executive officers of the Company for a two year period from the date a change in control occurs as further defined in the contracts.

On June 20, 2002, the Company, and subsequently its three principal competitors, were notified by the California Department of Health Services that they were in violation of the California Business and Professions Code, with respect to the drawing of blood by phlebotomists on a mobile basis. The Company disagreed with the Department’s interpretation of the law, retained legal counsel and is working with the Department to develop a reasonable interpretation of the law and a plan that will allow the Company to continue using phlebotomists to draw blood. On October 15, 2002, representatives of

Annual Report 2002    37

Hooper Holmes, Inc. and Subsidiaries

each of the four major paramedical companies, including Hooper Holmes, Inc., met with the Deputy Chief of the California Department of Health Services (DHS) to discuss the position taken by the DHS relative to the drawing of blood by non-licensed individuals on a mobile basis. The DHS waived certain requirements determined to be not applicable to the paramedical industry and has proposed a type of limited licensure for paramedical companies. The paramedical industry is presently working out the details of such licensure with the DHS and is confident that an agreement on licensure will be reached. The Company continues to service its customers in the State of California without interruption.

In the past, some state agencies have claimed that we improperly classified our examiners as independent contractors for purposes of state unemployment tax laws and that we were therefore liable for taxes in arrears, or for penalties for failure to comply with their interpretation of the laws. We received an adverse determination in the state of California, and as a result, converted our independent contractors to employees. Other similar state claims are also pending. We cannot be assured that we will prevail in these cases, or that we will not be subject to similar claims in other states in the future.

Note 9 — Litigation

The Company is party to a number of legal actions arising in the ordinary course of its business. In the opinion of management, the Company has substantial legal defenses and/or insurance coverage with respect to all of its other pending legal actions; accordingly, none of these actions is expected to have a material adverse effect on the Company’s liquidity, its results of operations or its consolidated financial position.

Note 10 — Goodwill and Intangible Assets

In July 2001, the Financial Accounting Standards Board (“FASB”) issued SFAS No. 142, “Goodwill and Other Intangible Assets.” Under the new rules, the Company was required to evaluate its existing intangible assets and goodwill that were acquired in purchase business combinations, and to make any necessary reclassifications in order to conform with the new classification criteria in SFAS No. 141 “Business Combinations”, for recognition separate from goodwill. Effective January 1, 2002, the date the Company adopted SFAS 142, the Company reclassified $.8 million of previously recorded value related to acquired work-force into goodwill and ceased amortizing this amount. The Company was also required to reassess the useful lives and residual values of all intangible assets acquired, and make any necessary amortization period adjustments by the end of the first interim period after adoption. For intangible assets identified as having indefinite useful lives, the Company was required to test those intangible assets for impairment in accordance with the provisions of SFAS No. 142 within the first interim period. Impairment was measured as the excess of carrying value over the fair value of an intangible asset with an indefinite life. The results of this analysis did not require the Company to recognize an impairment loss. The Company also completed its annual impairment test as of December 31, 2002 and did not have any impairment loss.

38    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

The following proforma information reconciles reported net income for the year ended December 31, 2002, 2001 and 2000 to adjusted net income, reflecting the impact of SFAS 142.

	Year ended
(in thousands except for earnings per share)	December 31, 2002	December 31, 2001	December 31, 2000
Net income	$14,293	$15,247	$20,964
Addback: Goodwill and related intangible amortization, net of tax	—	2,254	1,881
Adjusted net income	$14,293	$17,501	$22,845
Basic earnings per share:
Net income	$       .22	$       .24	$       .32
Goodwill amortization	—	.03	.03
Adjusted net income	$       .22	$       .27	$       .35
Diluted earnings per share
Net income	$       .21	$       .23	$       .31
Goodwill amortization	—	.03	.03
Adjusted net income	$       .21	$       .26	$       .34

The changes in the carrying amount of goodwill for the year ended December 31, 2002, are as follows:

Balance as of December 31, 2001	$  81,515,202
Acquisition goodwill	34,725,836
Foreign currency translation adjustment	31,909
Effect of adoption of SFAS No. 142 – workforce	802,597
Balance as of December 31, 2002	$117,075,544

The aggregate intangible amortization expense for the years ended December 31, 2002, 2001 and 2000 was approximately $2,944,000, $3,102,000 and $3,273,000, respectively. The estimated acquired intangible amortization expense for the fiscal years ending December 31, 2003 to December 31, 2007 is $3,932,000, $3,731,000, $3,127,000, $2,801,000 and $2,070,000, respectively.

During 2002, the Company completed several acquisitions which have resulted in the addition of $34.7 million of goodwill and $20.2 million of identifiable intangible assets to the consolidated financial statements. Intangible assets acquired consist of Customer Base of $16.3 million, Tradenames of $2.1 million, Non-Competition agreements of $1.4 million, and Physician Network of $.4 million. Amortization expense related to the acquired intangible assets for the year ended December 31, 2002 was approximately $.3 million.

Annual Report 2002    39

Hooper Holmes, Inc. and Subsidiaries

All intangible assets are being amortized over their estimated useful lives, as indicated below. Intangible assets consist of:

(in thousands)	Weighted Average Useful Life (Years)	Gross Carrying Amount		Accumulated Amortization			Net Balance
At December 31, 2002
Non-Competition agreements	4.9	$	8,405	$	(5,327	)	$	3,078
Referral base	13.4		25,594		(4,784	)		20,810
Contractor network	7.3		6,120		(3,955	)		2,165
Trademarks and tradenames	19.0		2,559		(138	)		2,421
		$	42,678	$	(14,204	)	$	28,474
At December 31, 2001
Non-Competition agreements	4.9	$	7,040	$	(4,313	)	$	2,727
Referral base	10.0		9,296		(3,616	)		5,680
Contractor network	7.0		5,708		(3,241	)		2,467
Assembled workforce	6.0		3,576		(2,773	)		803
Trademarks and tradenames	15.0		409		(90	)		319
		$	26,029	$	(14,033	)	$	11,996

Note 11 — Income Taxes

Income tax expense is comprised of the following:

(in thousands)	2002	2001		2000
Federal:
Current	$6,530	$  9,303		$11,554
Deferred	991	(545	)	724
State and local:
Current	1,407	2,094		2,697
Deferred	228	(175	)	195
	$9,156	$10,677		$15,170

The following reconciles the “statutory” federal income tax rates to the effective income tax rates:

	2002		2001	2000
Computed “expected” tax expense	35	%	35%	35%
Increase (reduction) in tax expense resulting from:
State tax, net of federal benefit	6		7	8
Non-tax deductible amortization of goodwill	—		2	1
Other	(2	)	(3)	(2)
Effective income tax rate	39	%	41%	42%

40    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

The tax effects of temporary differences that give rise to the deferred tax assets and liabilities at December 31, 2002 and 2001 are as follows:

(in thousands)	2002		2001
Deferred tax assets:
Discontinued operation accruals	$        24		$      25
Receivable allowance	496		396
Intangible assets	221		221
Insurance benefits	193		153
Litigation reserve	—		466
Other	697		204
	1,631		1,465
Deferred tax liabilities:
Accumulated depreciation	(263	)	(453	)
Acquisition bases adjustment, primarily intangibles	(3,374	)	(1,362	)
Other	(118	)	(209	)
	(3,755	)	(2,024	)
Net deferred tax liability	$(2,124	)	$   (559	)

Deferred tax assets (liabilities) are presented in the consolidated balance sheets at December 31, 2002 as follows: other current assets $1,359,000 and deferred income taxes (noncurrent liability) $(3,483,000) and at December 31, 2001, other current assets $1,183,000 and deferred income taxes (noncurrent liability) $(1,742,000).

No valuation allowance has been provided on deferred tax assets since management believes that it is more likely than not that such assets will be realized through the reversal of existing deferred tax liabilities and future taxable income. The amount of the valuation allowance could change in the near term if estimates of taxable income change.

The principal components of the deferred tax provision in 2002 and 2001 include differences between financial and tax reporting for depreciation and amortization.

Note 12 — Capital Stock

Stock Split and Authorized Shares — Effective January 8, 1999 and April 12, 2000, the Company declared two for one stock splits in the form of 100% stock dividends to all stockholders, which were distributed on January 29, 1999 and April 26, 2000, respectively. The stock splits resulted in additional shares of 14,189,982 shares and 33,160,626 shares of common stock, respectively, of which, 52,166 and 104,332 shares, respectively, were shares of treasury stock. All share and per share amounts have been retroactively restated for these events.

Stock Offering  — The Company completed a secondary common stock offering of 7,350,000 shares on February 29, 2000. The offering price was $12.563 and provided approximately $87 million in net proceeds to the Company.

Annual Report 2002    41

Hooper Holmes, Inc. and Subsidiaries

Stock Repurchase Program — On May 30, 2000, the Board of Directors authorized the repurchase in any calendar year of up to 2.5 million shares of the Company’s common stock for an aggregate purchase price not to exceed $25 million per year. For the years ended December 31, 2002, 2001 and 2000, the Company purchased 1,346,000, 1,347,000 and 1,785,000 shares at a total cost of $8.6 million, $10.8 million and $17.1 million, respectively.

Rights Agreement — On May 23, 2000, the Board of Directors adopted a Rights Agreement to replace the Rights Agreement which expired on June 16, 2000. The Board declared a dividend of one Common Share Purchase Right (a “Right”) for each outstanding share of Common Stock distributable on June 30, 2000.

The Rights Agreement was not adopted in response to any known effort to acquire control of the Company. Rather, the Rights Agreement was adopted in an effort to ensure that all of the Company’s shareholders are treated fairly in the event an attempt is made to take over the Company without paying all shareholders a full and fair price for all of their shares of Common Stock.

Until a person or group acquires 20% or more of the Company’s Common Stock or announces a tender or exchange offer to acquire 30% or more of the Company’s Common Stock (other than a Permitted Offer), the Rights will be evidenced by the Common Stock certificates, will automatically trade with the Common Stock and will not be exercisable. Thereafter, separate Rights certificates will be distributed. If (i) any person or group acquires 20% or more of the Company’s Common Stock (other than by a tender offer for all shares which the Company’s Board of Directors determines to be in the best interests of the Company and its shareholders, or by an inadvertent acquisition after which such person or group promptly divests a sufficient number of shares so that such person’s ownership is less than 20%) or (ii) the Company is involved in a merger or other business combination or sells more than 50% of its assets or earning power, each Right (other than Rights beneficially owned by 20% or more shareholders or certain transferees thereof, which Rights become void) will entitle the holder, upon payment of the exercise price of $110 (as adjusted), to buy a number of shares of Common Stock of the Company or of the acquiring company having a market value of twice the exercise price. If any person or group acquires between 20% and 50% of the Company’s Common Stock, the Company’s Board of Directors may, at its option, exchange each Right for a share of Company Common Stock.

The Rights Agreement will expire on June 15, 2010. In addition, the Rights may be redeemed for $0.01 per Right on or prior to the tenth day after any person or group acquires 20% or more of the Company’s Common Stock, thus clearing the way for an acquisition which the Board believes to be in the best interests of the Company and its shareholders.

Stock Purchase Plan — In 1993, the shareholders approved the 1993 Employee Stock Purchase Plan which provided for granting of purchase rights to all full-time employees, as defined, of up to 2,000,000 shares of Company stock. The plan provided for the purchase of shares on the date one year from the grant date. During the year after the grant date, up to 10% of an employee’s compensation was withheld for their purchase.

42    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Employees can cancel their purchases any time during the year, without penalty. The purchase price was 95% of the closing common stock price on the grant date. In April 1999 and April 2000, the Company distributed 161,808 and 136,124 shares, respectively, under the April 1998 and April 1999 grants, and the aggregate purchase price was $324,248 and $551,718, respectively. In April 2000, the Company made a grant of approximately 127,488 shares, and the aggregate purchase price was approximately $1,279,342; however, the 2000 plan offering terminated, in accordance with the plan’s automatic termination provision. In April 2002, the Company distributed 72,608 shares under the April 2001 grant at an aggregate purchase price of $551,821. Also in April 2002, the Company made a grant of approximately 66,237 shares, and the aggregate purchase price was approximately $550,429.

Stock Awards — The Company’s Chairman and President is entitled to receive stock awards based on the attainment of performance goals established for any given year. In the years ended December 31, 2002, 2001 and 2000, awards of 0 shares, 5,000 shares and 10,000 shares, respectively, have been granted.

Stock Option Plans — The Company’s stockholders approved stock option plans totaling 4,000,000 shares in 1994 and 1992, 2,400,000 shares in 1997, 2,000,000 shares in 1999 and 3,000,000 shares in 2002, which provide that options may be granted to management. Options are granted at fair value on the dates of the grants and are exercisable as follows: 25% after two years and 25% on each of three anniversary dates thereafter, and terminate after 10 years.

In May 1997, the Company’s stockholders approved the 1997 Director Stock Option Plan for 1,200,000 shares, which provides 200,000 options to non-employee Directors. The options were granted at fair value on the date of the grant, and are exercisable in five equal annual installments beginning on the first anniversary of the date of the grant. The Company currently has six non-employee directors.

Also in May 1997, the Company’s stockholders approved the CEO Stock Option Agreement, which provides options to the Chief Executive Officer to acquire 800,000 shares, at an exercise price equal to the fair value at the date of grant. The options vest 160,000 shares annually for five years. Any unvested options became immediately exercisable in 1999, because the two performance related conditions were met: (a) the Company’s earnings per share were at least $.18 for the year ended December 31, 1998, and (b) the Company’s closing stock price was at least $3.75 per share for any consecutive 30 day period during the six months ended June 30, 1999.

Annual Report 2002    43

Hooper Holmes, Inc. and Subsidiaries

The following table summarizes stock option activity:

	Under Option
	Shares Available for Grant		Shares		Weighted Average Exercise Price Per Share
Balance, December 31, 1999	2,614,708		9,740,700		$3.77
Granted	(501,500	)	501,500		7.13
Exercised	—		(1,589,000	)	2.33
Cancelled	106,000		(106,000	)	8.75
Balance, December 31, 2000	2,219,208		8,547,200		$4.17
Granted	(1,712,500	)	1,712,500		8.15
Exercised	—		(381,600	)	2.47
Cancelled	132,300		(132,300	)	9.76
Balance, December 31, 2001	639,008		9,745,800		$4.86
Authorized	3,000,000		—		—
Granted	(1,133,600	)	1,133,600		6.13
Exercised	—		(1,469,100	)	1.74
Cancelled	126,950		(126,950	)	7.39
Balance, December 31, 2002	2,632,358		9,283,350		$6.18

The weighted average fair value per stock option granted was $3.01 for the 2002 options, $4.50 for the 2001 options, and $4.36 for the 2000 options.

The following table summarizes information concerning options outstanding at December 31, 2002:

Options Outstanding				Options Exercisable
Range of Exercise Prices	Number Outstanding at 12/31/02	Weighted Average Remaining Contractual Term (Years)	Weighted Average Exercise Price	Number Exercisable at 12/31/02	Weighted Average Exercise Price
$     .98 –$  1.87	900,400	2.4	$  1.03	900,400	$  1.03
2.03 –    2.14	2,536,600	4.1	2.09	2,536,600	2.09
3.22 –    3.69	748,000	5.0	3.61	1,318,600	3.37
6.69 –    7.13	3,605,650	7.6	6.61	780,163	6.76
$10.76 –$12.88	1,492,700	7.2	$12.07	445,200	$12.88

Note 13 — 401k Savings and Retirement Plan

This plan is available to all employees with at least one year of service of greater than 1,000 hours of employment, and is administered by ING/ReliaStar Financial Corporation. The Company matches 25% of the first 10% of employee salary contributions. The Company’s payments for 2002, 2001 and 2000, were $432,000, $427,000 and $426,000, respectively. The Company’s common stock is not an investment option to employees participating in the 401k savings and retirement plan.

44    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Independent Auditors’ Report

The Board of Directors and Stockholders

Hooper Holmes, Inc.

We have audited the accompanying consolidated balance sheets of Hooper Holmes, Inc. and subsidiaries as of December 31, 2002 and 2001, and the related consolidated statements of income, stockholders’ equity and cash flows for each of the years in the three-year period ended December 31, 2002. These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits.

We conducted our audits in accordance with auditing standards generally accepted in the United States of America. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. An audit includes examining, on a test basis, evidence supporting the amounts and disclosures in the financial statements. An audit also includes assessing the accounting principles used and significant estimates made by management, as well as evaluating the overall financial statement presentation. We believe that our audits provide a reasonable basis for our opinion.

In our opinion, the consolidated financial statements referred to above present fairly, in all material respects, the financial position of Hooper Holmes, Inc. and subsidiaries as of December 31, 2002 and 2001, and the results of their operations and their cash flows for each of the years in the three-year period ended December 31, 2002, in conformity with accounting principles generally accepted in the United States of America.

As discussed in Notes 1 and 10 to the consolidated financial statements, the Company adopted the provisions of Statement of Financial Standards No. 142 “Goodwill and Other Intangible Assets” effective January 1, 2002.

KPMG LLP

Short Hills, New Jersey

February 26, 2003

Annual Report 2002    45

Hooper Holmes, Inc. and Subsidiaries

Selected Financial Data

	For the years ended December 31,
(dollars in thousands except per share data)	2002		2001		2000
Statement of Income Data:
Revenues	$	260,317	$	245,185	$	274,974
Operating income		21,872		24,111		32,633
Interest expense		113		204		1,291
Income from continuing operations		14,293		15,247		20,964
Loss from discontinued operations		—		—		—
Net income		14,293		15,247		20,964
Earnings per share — basic:
Income from continuing operations		.22		.24		.32
Discontinued operations		—		—		—
Net income		.22		.24		.32
Earnings per share — diluted:
Income from continuing operations		.21		.23		.31
Discontinued operations		—		—		—
Net income	$	.21	$	.23	$	.31
Cash dividends per share	$	.040	$	.030	$	.030
Weighted average shares — basic		64,868,163		64,895,764		64,830,697
Weighted average shares — diluted		67,229,119		67,618,151		68,377,742
Balance Sheet Data (as of December 31):
Working capital	$	58,776	$	94,059	$	93,305
Total assets		236,230		221,971		211,036
Current maturities of long-term debt		173		240		197
Long-term debt, less current maturities		3,314		3,280		3,195
Total long-term debt		3,487		3,520		3,392
Stockholders’ equity	$	205,807	$	196,407	$	191,077

Per share and share amounts are adjusted to reflect two for one stock splits effective August 22, 1997, January 8, 1999 and April 12, 2000.

46    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Selected Financial Data (continued)

	For the years ended December 31,
	1999		1998			1997		1996		1995			1994		1993
Statement of Income Data:
Revenues	$	237,068	$	185,210		$	165,353	$	156,254	$	111,313		$	92,534	$	80,600
Operating income		36,535		25,592			16,344		8,576		4,059			3,803		5,020
Interest expense		860		3			168		1,394		1,674			994		237
Income from continuing operations		20,793		14,185			8,770		4,086		1,667			1,480		2,739
Loss from discontinued operations		—		(1,485	)		—		—		(14,716	)		1,184		867
Net income		20,793		12,700			8,770		4,086		(13,049	)		2,664		3,606
Earnings per share — basic:
Income from continuing operations		.36		.25			.16		.08		.03			.03		.05
Discontinued operations		—		(.03	)		—		—		(.27	)		.02		.02
Net income		.36		.22			.16		.08		(.24	)		.05		.07
Earnings per share — diluted:
Income from continuing operations		.34		.24			.15		.08		.03			.03		.05
Discontinued operations		—		(.03	)		—		—		(.27	)		.02		.02
Net income	$	.34	$	.21		$	.15	$	.08	$	(.24	)	$	.05	$	.07
Cash dividends per share	$	.025	$	.018		$	.013	$	.008	$	.008		$	.038	$	.038
Weighted average shares — basic		57,560,564		56,241,370			55,073,336		53,821,752		53,657,024			53,653,704		53,712,488
Weighted average shares — diluted		61,533,558		59,719,420			57,128,264		54,487,604		53,809,428			53,831,164		54,083,472
Balance Sheet Data (as of December 31):
Working capital	$	56,076	$	33,476		$	20,381	$	11,807	$	24,786		$	6,407	$	4,024
Total assets		184,471		85,016			65,941		61,296		93,997			103,172		88,355
Current maturities of long-term debt		143		450			—		1,030		8,800			2,150		1,550
Long-term debt, less current maturities		65,307		—			—		5,250		26,250			46,327		29,950
Total long-term debt		65,450		450			—		6,280		35,050			48,477		31,500
Stockholders’ equity	$	89,692	$	62,294		$	48,519	$	37,719	$	33,132		$	46,502	$	45,916

Annual Report 2002    47

Hooper Holmes, Inc. and Subsidiaries

Directors

BENJAMIN A. CURRIER

Retired. Formerly Senior Vice President, Security Life of Denver Ins. Co. — ING/Barings

Mr. Currier, age 69, was Senior Vice President of Operations for Security Life of Denver Insurance Company, a subsidiary of ING/Barings, in Denver, Colorado prior to his retirement in 1997. Mr. Currier was Vice President, Allstate Life Insurance Company from 1978 to 1995. He has been a director of the Company since 1996, and is a member of the Audit Committee and the Executive Compensation Committee. (Term expires at the Annual Meeting in 2005.)

QUENTIN J. KENNEDY

Retired. Formerly Executive Vice President, Secretary and Director, Federal Paper Board Company

Mr. Kennedy, age 69, was Executive Vice President, Secretary, Treasurer and Director of Federal Paper Board Company in Montvale, New Jersey until his retirement in 1996. He had served in various executive positions with Federal Paper Board since 1960. Mr. Kennedy has been a director of the Company since 1991. He is a member of the Executive Committee and the Executive Compensation Committee. (Term expires at the Annual Meeting in 2003.)

JAMES M. MCNAMEE

Chairman, President and Chief Executive Officer

Mr. McNamee, age 58, has served as Chairman of the Board of Directors of the Company since 1996 and as President and Chief Executive Officer of the Company since 1984. He has been an employee of the Company since 1968, an officer since 1979 and a director since 1984. Mr. McNamee is a member of the Executive Committee and the Nominating and Corporate Governance Committee. (Term expires at the Annual Meeting in 2004.)

JOHN E. NOLAN

Partner, Steptoe & Johnson LLP

Mr. Nolan, age 75, is a partner in the law firm of Steptoe & Johnson, LLP, Washington, D.C. and has been engaged in the practice of law since 1956. He has been a director of the Company since 1971, and is a member of the Audit Committee and the Executive Committee. Mr. Nolan is also a director of Iomega Corporation. (Term expires at the Annual Meeting in 2003.)

ELAINE L. RIGOLOSI

Professor

Department of Organization and Leadership at Teachers College, Columbia University

Dr. Rigolosi, Ed.D, J.D., age 58, is Professor in the Department of Organization and Leadership at Teachers College, Columbia University. She has been associated with Columbia University since 1976, and has maintained a private consulting practice in management for health care organizations since 1974. Dr. Rigolosi has been a director of the Company since 1989, and is a member of the Audit Committee and the Executive Compensation Committee. (Term expires at the Annual Meeting in 2005.)

KENNETH R. ROSSANO

Private Investor.

Formerly Senior Vice President, Cassidy & Associates

Mr. Rossano, age 68, is a private investor. From 1992 to 1999, he was Senior Vice President, Cassidy & Associates in Boston, Massachusetts. From 1991 to 1992, he was Vice President, Development, Massachusetts Higher Education Assistance Corporation in Boston, Massachusetts. He has been a director of the Company since 1967, and is a member of the Executive Committee and the Nominating and Corporate Governance Committee. Mr. Rossano is also a director of Active International, Inc. and A+ America, Inc. and Chairman of the Katherine Gibbs School of Boston. (Term expires at the Annual Meeting in 2004.)

G. EARLE WIGHT

Retired, Formerly Senior Vice President, Hooper Holmes, Inc.

Mr. Wight, age 69, was Senior Vice President of the Company from 1985 until his retirement in 2002, and has been a director of the Company since 1966. Mr. Wight is a member of the Nominating and Corporate Governance Committee. (Term expires at the Annual Meeting in 2004.)

Officers

JAMES M. MCNAMEE

Chairman, President and Chief Executive Officer

MARIO L. CAVEZZA

Senior Vice President

DAVID J. GOLDBERG

Senior Vice President

ROBERT WILLIAM JEWETT

Senior Vice President, General Counsel and Secretary

STEVEN A. KARIOTIS

Senior Vice President

FRED LASH

Senior Vice President, Chief Financial Officer and Treasurer

JOSEPH A. MARONE

Vice President

RAYMOND A. SINCLAIR

Senior Vice President

ALEXANDER WARREN

Senior Vice President

48    Hooper Holmes, Inc.

Hooper Holmes, Inc. and Subsidiaries

Common Stock Information

· Traded on the American Stock Exchange (AMEX) under the symbol “HH”

· Options on HH common stock are also traded on the American Stock Exchange

· Included in Standard & Poor’s Small Cap 600 and Russell 2000 indices

· As of February 14, 2003 there were 1,123 shareholders of record.

Form 10-K

Holders of the Company’s common stock may obtain, without charge, a copy of the Hooper Holmes, Inc. Annual Report on Form 10-K as filed with the Securities and Exchange Commission upon request.

Address inquires to:

Secretary

Hooper Holmes, Inc.

170 Mt. Airy Road

Basking Ridge, NJ 07920

Independent Certified

Public Accountants

KPMG LLP

Short Hills, NJ

Transfer Agents & Registrar

Registrar and Transfer Company

Cranford, NJ

Annual Meeting

May 20, 2003,

at the Company’s Headquarters

Corporate Headquarters

Hooper Holmes, Inc.

170 Mt. Airy Road

Basking Ridge, NJ 07920

908.766.5000

www.hooperholmes.com

Dividend Reinvestment Plan

The Hooper Holmes Dividend Reinvestment Plan is designed to enable record shareholders of Hooper Holmes’ Common Shares to acquire additional Common Shares through the automatic investment of their cash dividends. With this Plan, there are no transaction charges or brokerage commissions associated with the purchase of Common Shares, thereby permitting the entire amount of your dividend to be invested. The Plan is administered for Hooper Holmes by Registrar and Transfer Company. For more information or an enrollment form, please contact Registrar and Transfer Company at 800.866.1340, ext. 2648.

Annual Report 2002    49

Hooper Holmes, Inc. and Subsidiaries

Quarterly Common Stock Price Range and Dividends

(dollars)

	2002						2001
Quarter		High		Low		Dividend		High		Low	Dividend
First	$	10.49	$	7.70	$	.01	$	11.73	$	8.00	$.0075
Second		10.98		8.00		.01		10.99		7.60	.0075
Third		8.01		5.00		.01		9.61		5.49	.0075
Fourth	$	6.98	$	5.50	$	.01	$	9.12	$	5.85	$.0075

Adjusted to reflect a two for one stock split effective April 12, 2000.

Quarterly Financial Data (Unaudited)

(dollars in thousands, except per share data)

					Per Share of Common Stock Net Income
Quarter		Revenues	Gross profit	Net Income	Basic	Diluted
2002
Fourth	$	68,221	$19,123	$  4,424	$.07	$.07
Third		59,591	15,864	136	—	—
Second		66,015	18,981	3,920	.06	.06
First		66,490	20,589	5,813	.09	.08
Total	$	260,317	$74,557	$14,293	$.22	$.21
2001
Fourth	$	63,590	$18,394	$  3,830	$.06	$.06
Third		57,238	15,756	3,246	.06	.05
Second		60,730	16,902	3,493	.05	.05
First		63,627	18,851	4,678	.07	.07
Total	$	245,185	$69,903	$15,247	$.24	$.23

Per share calculations are adjusted to reflect a two for one stock split effective April 12, 2000.

50    Hooper Holmes, Inc.

Glossary

Accretive

Adding to a company’s earnings, as in the case of a profitable acquisition.

Alternative Distribution Channels (ADCs)

“Non-traditional” methods for selling insurance, such as the Internet, banks and quote services.

Attending Physician Statement (APS)

Medical records obtained with written patient authorization for the purpose of underwriting life, health and disability insurance.

Corporate Governance

Issues associated with the management practices, Board structures and personnel policies of companies.

D&D Associates

A leading New York provider of Independent Medical Examination (IME) case management services, acquired in 2002. D&D’s services support Personal Injury Protection claims, Automobile No-Fault Liability claims and Worker’s Compensation claims, primarily for property and casualty insurers and claims reviewers.

DSO (days sales outstanding)

The average collection period on sales-related accounts receivable.

Earnings per Share – Basic

Net income divided by the number of shares outstanding during the period.

Earnings per Share – Diluted

Net income divided by the sum of weighted average number of shares outstanding during the period plus shares assumed to be issued if all outstanding stock options were exercised.

EBITDA

Earnings before interest, taxes, depreciation and amortization.

e-mobile exam^™

Hooper Holmes’ proprietary wireless exam-data capture program and transmitter.

Goodwill

An intangible asset that provides a competitive advantage, such as a strong brand, reputation, favorable location or high employee morale.

Health Information Services

The core service of Hooper Holmes: collecting health information for the purpose of underwriting life, health and disability insurance.

Healthdex Service Group

Hooper Holmes’ data gathering service specifically dedicated to the biotech and pharmaceutical industries in support of clinical trials and sales and marketing activities.

Heritage Labs

A subsidiary of Hooper Holmes, Heritage Labs is a full-service, progressive laboratory serving the insurance industry. Heritage assembles collection kits for use by paramedical companies, and analyzes blood, urine and oral-fluid samples and transmits the results to the ordering insurance company.

Independent Medical Exams (IME)

An impartial medical examination performed by an independent physician, usually at the request of an insurer in order to evaluate a claim.

Infolink Services Group

Developed to complement the paramedical services provided by Portamedic^®. Products include Inspection Reports and Attending Physician Statements.

Medicals Direct Group

The market leader in the U.K. in providing paramedical examinations and underwriting services to the life insurance industry, acquired in 2002.

Online Forms Library

An online catalog of insurance exam forms organized by participating insurer and state, for use by Hooper Holmes’ branch employees.

Operating Income

Earnings from the operation of our business services, not including interest expense, interest income and other non-operations income (expense), net.

Paramedical Exam

A 20 to 30 minute medical exam performed to record an applicant’s abbreviated medical history, height and weight measurements, blood pressure and pulse. Depending on the requirements of the ordering insurance company, a urine, blood and/or saliva sample may also be collected.

Portamedic^®

Hooper Holmes’ health information division, which conducts physical examinations, testing and personal health interviews primarily for the life and health insurance industry.

Portamedic.com

Portamedic’s Web site, designed to increase the service, efficiency and order-status visibility for Hooper Holmes’ clients.

Portamedic F.A.S.T.^™

An imaging solution whereby clients can retrieve, view and print images of APS’s, examinations and personal health interviews within 24 hours of completion.

Portamedic Select^™

A comprehensive process for gathering the requirements needed to initiate the underwriting process, enabling insurers to issue policies up to 70% faster.

Pro Forma

Description of financial statements that have one or more assumptions or hypothetical conditions built into the data.

Return on Stockholders’ Equity

Net income divided by average stockholders’ equity; a measure of the rate of return on a common stockholder’s investment.

Teledex

Portamedic’s telephone-interview call center.

Share Repurchase (Stock Buyback)

Program by which a corporation buys back its own shares in the open market—usually done when shares are undervalued. Since it reduces the number of shares outstanding and thus increases earnings per share, it tends to elevate the market value of the remaining shares held by stockholders.

Underwriting

The process by which life and health insurance companies gather information to assess risks in order to make informed decisions as to the issuance of policies to applicants.

Hooper Holmes, Inc.

Corporate Headquarters

170 Mt. Airy Road

Basking Ridge, NJ 07920

908.766.5000

www.hooperholmes.com

EX-21

EXHIBIT 21

SUBSIDIARIES OF HOOPER HOLMES, INC.

Subsidiary Name	State of Incorporation	Business Names
“684” Associates, Ltd.	New York	D & D Associates

EX-23

Exhibit 23

INDEPENDENT AUDITORS’ CONSENT

The Board of Directors

Hooper Holmes, Inc.

We consent to incorporation by reference in the registration statements on Form S-3 (No. 333-57769) and on Form S-8 (No. 333-72422, No. 333-57771, No. 333-04785 and No. 33-53086) of Hooper Holmes, Inc. of our report dated February 26, 2003, relating to the consolidated balance sheets of Hooper Holmes, Inc. and subsidiaries as of December 31, 2002 and 2001, and the related consolidated statements of income, shareholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2002, which report appears in the December 31, 2002, annual report on Form 10-K of Hooper Holmes, Inc.

Our report on the consolidated financial statements refers to the Company’s adoption of Statement of Financial Accounting Standards No. 142 “Goodwill and Other Intangible Assets” effective January 1, 2002.

/s/    KPMG LLP

KPMG LLP

Short Hills, New Jersey

March 31, 2003

EX-24

EXHIBIT 24

POWER OF ATTORNEY

The undersigned Director of Hooper Holmes, Inc., a New York corporation (the “Company”), which proposes to file a Form 10-K Annual Report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934, for the fiscal year ended December 31, 2002, hereby appoints James M. McNamee and Robert William Jewett, or either of them, his attorneys in fact, and hereby grants to him, for him and in his name as such Director, full power and authority as his agent or agents and in his place and stead:

1. to sign such Annual Report on Form 10-K and any subsequent amendment thereto, and any and all other amendments or documents related thereto which any of said attorneys in fact, in his discretion, may deem necessary or proper; and

2. to perform every other act which any of said attorneys in fact, in his discretion, may deem necessary or appropriate in connection with such Annual Report or any amendments thereto.

DATED:  March 27, 2003

/s/    JOHN E. NOLAN        

John E. Nolan

POWER OF ATTORNEY

The undersigned Director of Hooper Holmes, Inc., a New York corporation (the “Company”), which proposes to file a Form 10-K Annual Report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934, for the fiscal year ended December 31, 2002, hereby appoints James M. McNamee and Robert William Jewett, or either of them, his attorneys in fact, and hereby grants to him, for him and in his name as such Director, full power and authority as his agent or agents and in his place and stead:

1. to sign such Annual Report on Form 10-K and any subsequent amendment thereto, and any and all other amendments or documents related thereto which any of said attorneys in fact, in his discretion, may deem necessary or proper; and

2. to perform every other act which any of said attorneys in fact, in his discretion, may deem necessary or appropriate in connection with such Annual Report or any amendments thereto.

DATED:  March 27, 2003

/s/    ELAINE RIGOLOSI        

Elaine Rigolosi

POWER OF ATTORNEY

The undersigned Director of Hooper Holmes, Inc., a New York corporation (the “Company”), which proposes to file a Form 10-K Annual Report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934, for the fiscal year ended December 31, 2002, hereby appoints James M. McNamee and Robert William Jewett, or either of them, his attorneys in fact, and hereby grants to him, for him and in his name as such Director, full power and authority as his agent or agents and in his place and stead:

1. to sign such Annual Report on Form 10-K and any subsequent amendment thereto, and any and all other amendments or documents related thereto which any of said attorneys in fact, in his discretion, may deem necessary or proper; and

2. to perform every other act which any of said attorneys in fact, in his discretion, may deem necessary or appropriate in connection with such Annual Report or any amendments thereto.

DATED:  March 27, 2003

/s/    KENNETH R. ROSSANO        

Kenneth R. Rossano

POWER OF ATTORNEY

The undersigned Director of Hooper Holmes, Inc., a New York corporation (the “Company”), which proposes to file a Form 10-K Annual Report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934, for the fiscal year ended December 31, 2002, hereby appoints James M. McNamee and Robert William Jewett, or either of them, his attorneys in fact, and hereby grants to him, for him and in his name as such Director, full power and authority as his agent or agents and in his place and stead:

1. to sign such Annual Report on Form 10-K and any subsequent amendment thereto, and any and all other amendments or documents related thereto which any of said attorneys in fact, in his discretion, may deem necessary or proper; and

2. to perform every other act which any of said attorneys in fact, in his discretion, may deem necessary or appropriate in connection with such Annual Report or any amendments thereto.

DATED:  March 27, 2003

/s/    QUENTIN J. KENNEDY        

Quentin J. Kennedy

POWER OF ATTORNEY

The undersigned Director of Hooper Holmes, Inc., a New York corporation (the “Company”), which proposes to file a Form 10-K Annual Report pursuant to Section 13 or 15 (d) of the Securities Exchange Act of 1934, for the fiscal year ended December 31, 2002, hereby appoints James M. McNamee and Robert William Jewett, or either of them, his attorneys in fact, and hereby grants to him, for him and in his name as such Director, full power and authority as his agent or agents and in his place and stead:

1. to sign such Annual Report on Form 10-K and any subsequent amendment thereto, and any and all other amendments or documents related thereto which any of said attorneys in fact, in his discretion, may deem necessary or proper; and

2. to perform every other act which any of said attorneys in fact, in his discretion, may deem necessary or appropriate in connection with such Annual Report or any amendments thereto.

DATED:  March 27, 2003

/s/    BENJAMIN A. CURRIER        

Benjamin A. Currier

EX-99.1

EXHIBIT 99.1

CERTIFICATION

PURSUANT TO

18 U.S.C. SECTION 1350

The undersigned, James M. McNamee, the Chief Executive Officer, and Fred Lash, the Chief Financial Officer, of Hooper Holmes, Inc. (the “Company”), pursuant to 18 U.S.C. §1350, each hereby certifies that:

(i)    This annual report on Form 10-K for the fiscal year ended December 31, 2002 (the “Report”) fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(ii)    the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:    March 31, 2003

/s/    James M. McNamee

James M. McNamee

Chairman, President and

Chief Executive Officer

/s/    Fred Lash

Fred Lash

Senior Vice President, Treasurer and

Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Hooper Holmes, Inc. and will be retained by Hooper Holmes, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.